cats20180630

0001437749-18-015583.txt : 20180814 0001437749-18-015583.hdr.sgml : 20180814 20180814160451 ACCESSION NUMBER: 0001437749-18-015583 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180814 DATE AS OF CHANGE: 20180814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CATASYS, INC. CENTRAL INDEX KEY: 0001136174 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 880464853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31932 FILM NUMBER: 181017339 BUSINESS ADDRESS: STREET 1: 11601 WILSHIRE BLVD. STREET 2: SUITE 1100 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310 444 4300 MAIL ADDRESS: STREET 1: 11601 WILSHIRE BLVD. STREET 2: SUITE 1100 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: HYTHIAM, INC. DATE OF NAME CHANGE: 20101029 FORMER COMPANY: FORMER CONFORMED NAME: HYTHIAM INC DATE OF NAME CHANGE: 20031003 FORMER COMPANY: FORMER CONFORMED NAME: ALASKA FREIGHTWAYS INC DATE OF NAME CHANGE: 20010305 10-Q 1 cats20180630_10q.htm FORM 10-Q cats20180630_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2018

Commission File Number 001-31932

CATASYS, INC.

(Exact name of registrant as specified in its charter)

Delaware	88-0464853
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

11601 Wilshire Boulevard, Suite 1100, Los Angeles, California 90025

(Address of principal executive offices, including zip code)

(310) 444-4300

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,’’ “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☑

As of August 13, 2018, there were 15,913,171 shares of the registrant's common stock, $0.0001 par value per share, outstanding.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION			3

ITEM 1. Financial Statements			3

Condensed Consolidated Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017			3

Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2018 and 2017 (unaudited)			4

Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2018 and 2017 (unaudited)			5

Condensed Consolidated Statements of Stockholders Equity (Deficit) for the Six Months Ended June 30, 2018 (unaudited)			6

Notes to Condensed Consolidated Financial Statements			7

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations			20

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk			28

ITEM 4. Controls and Procedures			28

PART II – OTHER INFORMATION			30

ITEM 1. Legal Proceedings			30

ITEM 1A. Risk Factors			30

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds			30

ITEM 3. Defaults Upon Senior Securities			30

ITEM 4. Mine Safety Disclosures			30

ITEM 5. Other Information			30

ITEM 6. Exhibits			30

In this Quarterly Report on Form 10-Q, except as otherwise stated or the context otherwise requires, the terms “the Company,” “Our Company,” “we,” “us,” or “our” refer to Catasys, Inc. and our wholly-owned subsidiaries. Our common stock, par value $0.0001 per share, is referred to as “common stock.”

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	(unaudited)
(In thousands, except for number of shares)	June 30,			December 31,
	2018			2017
ASSETS
Current assets
Cash and cash equivalents	$	5,603		$	4,779
Receivables, net of allowance for doubtful accounts of $0 and $476, respectively		1,140			511
Prepaids and other current assets		201			366
Total current assets		6,944			5,656
Long-term assets
Property and equipment, net of accumulated depreciation of $1,688 and $1,542, respectively		374			612
Deposits and other assets		578			336
Total Assets	$	7,896		$	6,604

LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT)
Current liabilities
Accounts payable	$	1,215		$	980
Accrued compensation and benefits		1,403			1,177
Deferred revenue		3,416			2,914
Other accrued liabilities		1,567			578
Total current liabilities		7,601			5,649
Long-term liabilities
Long term debt, net of discount of $434 and $0, respectively		4,865			-
Deferred rent and other long-term liabilities		-			25
Capital leases		-			2
Warrant liabilities		59			30
Total Liabilities		12,525			5,706

Stockholders' (deficit)/equity
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding		-			-
Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,913,171 and 15,889,171 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively		2			2
Additional paid-in-capital		295,234			294,220
Accumulated deficit		(299,865	)		(293,324	)
Total Stockholders' (Deficit)/Equity		(4,629	)		898
Total Liabilities and Stockholders' (Deficit)/Equity	$	7,896		$	6,604

See accompanying notes to the condensed consolidated financial statements.

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended						Six Months Ended
(In thousands, except per share amounts)	June 30,						June 30,
	2018			2017			2018			2017
Revenues
Healthcare services revenues	$	3,273		$	1,665		$	5,184		$	3,487

Operating expenses
Cost of healthcare services		2,941			1,332			5,228			2,697
General and administrative		4,392			2,940			8,178			5,569
Depreciation and amortization		85			45			170			84
Total operating expenses		7,418			4,317			13,576			8,350

Loss from operations		(4,145	)		(2,652	)		(8,392	)		(4,863	)

Other income		-			14			40			28
Interest expense		(36	)		(539	)		(37	)		(3,406	)
Loss on conversion of note		-			(430	)		-			(1,356	)
Loss on issuance of common stock		-			(145	)		-			(145	)
Change in fair value of warrant liability		(19	)		6,950			(29	)		1,769
Change in fair value of derivative liability		-			10,728			-			132
Income/(Loss) from operations before provision for income taxes		(4,200	)		13,926			(8,418	)		(7,841	)
Provision for income taxes		-			1			-			2
Net Income/(Loss)	$	(4,200	)	$	13,925		$	(8,418	)	$	(7,843	)


Basic net income (loss) from operations per share:	$	(0.26	)	$	1.00		$	(0.53	)	$	(0.68	)

Basic weighted number of shares outstanding		15,913			13,885			15,906			11,578

Diluted net income (loss) from operations per share:	$	(0.26	)	$	0.97		$	(0.53	)	$	(0.68	)

Diluted weighted number of shares outstanding		15,913			14,299			15,906			11,578

See accompanying notes to the condensed consolidated financial statements.

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

	Six Months Ended
(In thousands)	June 30,
	2018			2017
Operating activities:
Net loss	$	(8,418	)	$	(7,843	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		170			84
Amortization of debt discount included in interest expense		10			3,335
Warrants issued for services		86			-
Loss on disposal of fixed asset		68			-
Provision for doubtful accounts		-			234
Deferred rent		(45	)		(39	)
Share-based compensation expense		753			159
Fair value adjustment on derivative liability		-			(132	)
Fair value adjustment on warrant liability		29			(1,769	)
Shares issued for services		112			181
Loss on conversion of note		-			1,356
Loss on issuance of common stock		-			145
Changes in current assets and liabilities:
Receivables		(629	)		(169	)
Prepaids and other current assets		165			242
Deferred revenue		2,379			843
Accounts payable and other accrued liabilities		1,486			164
Net cash used in operating activities	$	(3,834	)	$	(3,209	)

Investing activities:
Purchases of property and equipment	$	-		$	(127	)
Net cash used in investing activities	$	-		$	(127	)

Financing activities:
Proceeds of issuance of common stock	$	-		$	16,458
Proceeds from bridge loan		-			1,300
Payment of convertible debentures		-			(4,363	)
Transaction costs		-			(1,667	)
Proceeds from secured promissory note		5,000			-
Debt issuance costs		(324	)		-
Capital lease obligations		(18	)		(21	)
Net cash provided by financing activities	$	4,658		$	11,707

Net increase in cash and cash equivalents	$	824		$	8,371
Cash and cash equivalents at beginning of period		4,779			851
Cash and cash equivalents at end of period	$	5,603		$	9,222

Supplemental disclosure of cash paid
Income taxes	$	-		$	40
Supplemental disclosure of non-cash activity
Common stock issued for conversion of debt and accrued interest	$	-		$	7,163
Common stock issued upon settlement of deferred compensation to officer	$	-		$	1,122
Warrants issued in connection with A/R Facility	$	63		$	-

See accompanying notes to the condensed consolidated financial statements.

CATASYS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT)/EQUITY

					Additional
(Amounts in thousands, except for number of shares)	Common Stock				Paid-In		Accumulated
	Shares		Amount		Capital		Deficit			Total

Balance at December 31, 2017		15,889,171	$	2	$	294,220	$	(293,324	)	$	898
Adoption of accounting standard		-		-		-		1,877			1,877
Balance at January 1, 2018		15,889,171		2		294,220		(291,447	)		2,775

Common stock issued for outside services		24,000		-		112		-			112
Warrants issued for services		-		-		86		-			86
Warrants issued in connection with A/R facility		-		-		63		-			63
Share-based compensation expense		-		-		753		-			753
Net loss		-		-		-		(8,418	)		(8,418	)
Balance at June 30, 2018		15,913,171	$	2	$	295,234	$	(299,865	)	$	(4,629	)

See accompanying notes to the condensed consolidated financial statements.

Catasys, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(unaudited)

Note 1. Basis of Consolidation and Presentation

We harness proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives

The accompanying unaudited condensed consolidated financial statements for Catasys, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and instructions to Form 10-Q and, therefore, do not include all disclosures necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. GAAP. In our opinion, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the entire fiscal year. The accompanying financial information should be read in conjunction with the financial statements and the notes thereto included in our most recent Annual Report on Form 10-K for the year-ended December 31, 2017, from which the balance sheet, as of December 31, 2017, have been derived.

Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our OnTrak solutions in twenty states. We provide services to commercial (employer funded), managed Medicare Advantage, and managed Medicaid and duel eligible (Medicare and Medicaid) populations. We have generated fees from our launched programs and expect to increase enrollment and fees throughout 2018.

Management’s Plans

In June 2018 we entered into a venture loan and security agreement (the “Loan Agreement”) with Horizon Technology Finance Corporation (the “Lender”), which provides for up to $7.5 million in loans to the Company, including initial loans in the amount of $5.0 million funded upon signing of the Loan Agreement. An additional $2.5 million loan is subject to the Company’s achievement of billings of not less than $5.0 million during any three consecutive month period on or prior to November 30, 2018. Also, in June 2018, we entered into a loan and security agreement in connection with a $2.5 million receivables financing facility with Corporate Finance, a division of Heritage Bank of Commerce (the “A/R Facility”). The A/R Facility provides for the borrower entities to borrow up to 85% of the Company’s eligible accounts receivable, as defined in the A/R Facility.

Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not reflect any adjustments that might result if we were unable to continue as a going concern. We entered into contracts for additional revenue-generating health plan customers and expanding our OnTrak program within existing health plan customers. To support this increased demand for services, we invested in the additional headcount needed to support these customers launching during the first half of 2018. We have had a growing customer base and are able to fully scale our operations to service the contracts and future enrollment providing leverage in these investments that is expected to result in positive cash flow during the second quarter of 2019. Based upon this expected positive cash flow, we believe we will have enough capital to cover expenses through at least the next twelve months. We will continue to monitor liquidity carefully and in the event we do not have enough capital to cover expense we will make the necessary and appropriate reductions in spending to remain cash flow positive. However, if we were to add more health plans than budgeted, increase the size of the outreach pool by more than we anticipate, decide to invest in new products or seek out additional growth opportunities, we would look to finance these options via a debt financing rather than an equity financing, subject to complying with certain restrictions on the incurrence of indebtedness in our current lending facilities.

All inter-company transactions have been eliminated in consolidation.

Note 2. Summary of Significant Accounting Policies

Revenue Recognition

Revenue from contracts with customers is recognized when, or as, we satisfy our performance obligations by transferring the promised goods or services to the customers. A good or service is transferred to a customer when, or as, the customer obtains control of that good or service. A performance obligation may be satisfied over time or at a point in time. Revenue from a performance obligation satisfied over time is recognized by measuring our progress in satisfying the performance obligation in a manner that depicts the transfer of the goods or services to the customer. Revenue from a performance obligation satisfied at a point in time is recognized at the point in time that we determine the customer obtains control over the promised good or service. The amount of revenue recognized reflects the consideration we expect to be entitled to in exchange for those promised goods or services (i.e., the “transaction price”). In determining the transaction price, we consider multiple factors, including the effects of variable consideration. Variable consideration is included in the transaction price only to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainties with respect to the amount are resolved. In determining when to include variable consideration in the transaction price, we consider the range of possible outcomes, the predictive value of our past experiences, the time period of when uncertainties expect to be resolved and the amount of consideration that is susceptible to factors outside of our influence, such as the judgment and actions of third parties.

The following table disaggregates our revenue by contract (in thousands):

	Three Months Ended June 30, 2018					Six Months Ended June 30, 2018
	Revenue		Percentage			Revenue		Percentage

Commercial	$	2,145		66	%	$	3,245		63	%
Government		1,128		34	%		1,939		37	%
	$	3,273		100	%	$	5,184		100	%

Because the Company’s contracts have an expected duration of one year or less, the Company has elected the practical expedient in Accounting Standards Codification (“ASC”) 606-10-50-14(a) to not disclose information about its remaining performance obligations.

Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis, an upfront case rate, or fee for service based on enrolled members. The Company’s performance obligation is satisfied over time as the OnTrak service is provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing a continuous service to the customer. Contracts with minimum performance guarantees or price concessions include variable consideration and are subject to the revenue constraint. The Company uses an expected value method to estimate variable consideration for minimum performance guarantees and price concessions. The Company has constrained revenue for expected price concessions during the period ending June 30, 2018.

Cost of Services

Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third party administrators for processing these claims. Salaries and fees charged by our third party administrators for processing claims are expensed when incurred and healthcare provider claims payments are recognized in the period in which an eligible member receives services. We contract with doctors and licensed behavioral healthcare professionals, on a fee-for-service basis. We determine that a member has received services when we receive a claim or in the absence of a claim, by utilizing member data recorded in the OnTrak^TMdatabase within the contracted timeframe, with all required billing elements correctly completed by the service provider.

Cash Equivalents and Concentration of Credit Risk

We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents. Cash is deposited with what we believe are highly credited, quality financial institutions. The deposited cash may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. As of June 30, 2018, we had $5.4 million in cash and cash equivalents exceeding federally insured limits.

For the six months ended June 30, 2018, five customers accounted for approximately 93% of revenues (26%, 25%, 16%, 15%, and 11%) and three customers accounted for approximately 71% of accounts receivable (42%, 17%, and 12%).

For the three months ended June 30, 2018, two customers accounted for approximately 36% of revenues (19% and 17%).

Basic and Diluted Income (Loss) per Share

Basic income (loss) per share is computed by dividing the net loss to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss for the period by the weighted average number of common stock and dilutive common equivalent shares outstanding during the period.

Common equivalent shares, consisting of 4,571,912 and 2,255,381 common shares for the six months ended June 30, 2018 and 2017, issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.

Common equivalent shares, consisting of 413,701 incremental common shares for the three months ended June 30, 2017, issuable upon the exercise of warrants have been included in the diluted earnings per share calculation.

	Three Months Ended					Six Months Ended
	June 30					June 30
(in thousands, except per share amounts)	2018			2017		2018			2017

Numerator

Net income (loss)	$	(4,200	)	$	13,925	$	(8,418	)	$	(7,843	)

Denominator

Weighted-average common shares outstanding		15,913			13,885		15,906			11,578

Shares used in calculation - basic		15,913			13,885		15,906			11,578

Shares issuable for stock options and warrants		-			414		-			-

Shares used in calculation - diluted		15,913			14,299		15,906			11,578

Net income (loss) per share from operations

Basic	$	(0.26	)	$	1.00	$	(0.53	)	$	(0.68	)

Diluted	$	(0.26	)	$	0.97	$	(0.53	)	$	(0.68	)

Share-Based Compensation

Our 2017 Stock Incentive Plan (the “2017 Plan”), provides for the issuance of up to 2,333,334 shares of our common stock and an additional 243,853 shares of our common stock that are represented by awards granted under our 2010 Stock Incentive Plan (the “2010 Plan”). Incentive stock options (ISOs) under Section 422A of the Internal Revenue Code and non-qualified options (NSOs) are authorized under the 2017 Plan. We have granted stock options to executive officers, employees, members of our board of directors, and certain outside consultants. The terms and conditions upon which options become exercisable vary among grants, but option rights expire no later than ten years from the date of grant and employee and board of director awards generally vest over three to five years. As of June 30, 2018, we had 2,526,664 shares outstanding, of which 368,609 shares are vested and 50,523 shares are available for future awards under the 2017 Plan.

Share-based compensation expense attributable to operations were approximately $425,000 and $753,000 for the three and six months ended June 30, 2018, respectively compared with approximately $32,000 and $159,000 for the same periods in 2017, respectively.

Stock Options – Employees and Directors

We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations.

For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our consolidated statements of operations for the three and six months ended June 30, 2018 and 2017 is based on awards ultimately expected to vest, reduced for estimated forfeitures. Accounting rules for stock options require forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

There were 642,307 options granted to employees and directors during the three and six months ended June 30, 2018 compared with no options granted during the same periods in 2017. Employee and director stock option activity for the six months ended June 30, 2018 are as follows:

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2017		1,885,383		$	11.46

Granted		642,307			7.50
Cancelled		(1,026	)		546.19

Balance June 30, 2018		2,526,664		$	10.24

The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three and six months ended June 30, 2018 and 2017, reflects the application of the simplified method prescribed in Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 107 (as amended by SAB 110), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.

As of June 30, 2018, there was $6.7 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2017 Plan. That cost is expected to be recognized over a weighted-average period of approximately 3.5 years.

Stock Options and Warrants – Non-employees

We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends.

For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method.

There were no options issued to non-employees for the three and six months ended June 30, 2018 or in the same periods in 2017.

There was no share-based compensation expense relating to stock options and warrants recognized for non-employees for the three and six months ended June 30, 2018 or in the same periods in 2017.

There were 0 and 24,000 warrants issued in exchange for services during the three months and six months ended June 30, 2018, compared with 90,000 options issued in exchange for services during the same periods in 2017. Generally, the costs associated with warrants issued for services are amortized to the related expense on a straight-line basis over the related service periods.

There were 9,720 warrants issued in connection with the June 2018 A/R Facility financing (see Footnote 4).

There were 2,045,248 and 2,011,528 warrants outstanding as of June 30, 2018 and 2017, respectively.

Common Stock

There were 0 and 24,000 shares of common stock issued in exchange for investor relations services during the three and six months ended June 30, 2018, respectively, compared with 14,493 and 28,985 for the same periods in 2017. Generally, the costs associated with shares issued for services are amortized to the related expense on a straight-line basis over the related service periods.

In April 2017, we entered into an underwriting agreement with Joseph Gunnar & Co., LLC (“Joseph Gunnar”), as underwriter in connection with a public offering of the Company’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate 3,125,000 shares of common stock at a public offering price of $4.80 per share, and the purchase price to the underwriter after discounts and commission was $4.464 per share. The closing of the offering occurred on April 28, 2017. We received $15.0 million in gross proceeds in connection with the offering.

Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a 45 day over-allotment option to purchase up to 468,750 additional shares of common stock at the public offering price less the applicable underwriter discount. In May, the underwriter acquired an additional 303,750 shares pursuant to such over-allotment option. We received $1.5 million in gross proceeds in connection with the over-allotment option.

In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on April 26, 2017.

In April 2017, several investors, including Acuitas Group Holdings, LLC (“Acuitas”), one hundred percent (100%) of which is owned by Terren S. Peizer, Chairman and Chief Executive Officer of the Company, and Shamus, LLC (“Shamus”), a Company owned by David E. Smith, a member of our board of directors, exercised their option to convert their convertible debentures and received 2,982,994 shares of common stock. There was a loss on the conversion of the convertible debentures of $1.4 million for the six months ended June 30, 2017.

In April 2017, Terren S. Peizer agreed to settle his deferred salary balance of $1.1 million for 233,734 shares of common stock. As a result, the Company recognized a loss on settlement of liability totaling $83,807 which is recorded to loss on issuance of common stock.

In April 2017, we filed a certificate of amendment to our Certificate of Incorporation, as amended and in effect, with the Secretary of State of the State of Delaware, implementing a 1-for-6 reverse stock split of the Company's common stock, pursuant to which each six shares of issued and outstanding common stock converted into one share of common stock. Proportionate voting rights and other rights of common stock holders were not affected by the reverse stock split. No fractional shares of common stock were issued as a result of the reverse stock split; stockholders were paid cash in lieu of any such fractional shares.

All stock options and warrants to purchase common stock outstanding and our Common Stock reserved for issuance under the Company's equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by six and, as applicable, multiplying the exercise price by six as a result of the reverse stock split.

Income Taxes

We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of June 30, 2018. As such, we have not recorded a provision for income tax for the period ended June 30, 2018. We utilize the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.

We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% likelihood that a tax benefit will be sustained, we have recorded the largest amount of tax benefit that may potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements. Based on management's assessment of the facts, circumstances and information available, management has determined that all of the tax benefits for the period ended June 30, 2018 should be realized.

Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The three levels of the fair value hierarchy are described below:

Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II		Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at June 30, 2018 for assets and liabilities measured at fair value:

	Balance at June 30, 2018


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		71		-		-		71
Total assets		71		-		-		71

Warrant liabilities		-		-		59		59
Total liabilities		-		-		59		59

Financial instruments classified as Level III in the fair value hierarchy as of June 30, 2018, represent our liabilities measured at market value on a recurring basis which include warrant liabilities resulting from recent debt financings. In accordance with current accounting rules, the warrant liabilities with anti-dilution protection are being marked-to-market each quarter-end until they are completely settled or expire. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See Warrant Liabilities below.

The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the six months ended June 30, 2018:

	Level III
	Warrant
(Dollars in thousands)	Liabilities
Balance as of December 31, 2017	$	30
Issuance of warrants		-
Change in fair value		29
Balance as of June 30, 2018	$	59

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two to seven years for furniture and equipment. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the related lease term, which is typically five to seven years.

Variable Interest Entities

Generally, an entity is defined as a Variable Interest Entity (“VIE”) under current accounting rules if it has (a) equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support from other parties, or (b) equity investors that cannot make significant decisions about the entity’s operations, or that do not absorb the expected losses or receive the expected returns of the entity. When determining whether an entity that is a business qualifies as a VIE, we also consider whether (i) we participated significantly in the design of the entity, (ii) we provided more than half of the total financial support to the entity, and (iii) substantially all of the activities of the VIE either involve us or are conducted on our behalf. A VIE is consolidated by its primary beneficiary, which is the party that absorbs or receives a majority of the entity’s expected losses or expected residual returns.

As discussed under the heading Management Services Agreement (“MSA”) below, we have an MSA with a Texas nonprofit health organization (“TIH”). Under this MSA, the equity owner of TIH has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We participate significantly in the design of this MSA. We also agree to provide working capital loans to allow for TIH to pay for its obligations. Substantially all of the activities of TIH either involve us or are conducted for our benefit, as evidenced by the facts that (i) the operations of the TIH are conducted primarily using our licensed network of providers and (ii) under the MSA, we agree to provide and perform all non-medical management and administrative services for the medical group. Payment of our management fee is subordinate to payments of the obligations of TIH, and repayment of the working capital loans is not guaranteed by the equity owner of the affiliated medical group or other third party. Creditors of TIH do not have recourse to our general credit.

Based on the design and provisions of this MSA and the working capital loans provided to the medical group, we have determined that TIH is a VIE, and that we are the primary beneficiary as defined in the current accounting rules. Accordingly, we are required to consolidate the revenues and expenses of the managed medical corporation.

Management Services Agreement

In April 2018, we executed an MSA with TIH. Under the MSA, we license to TIH the right to use our proprietary treatment programs and related trademarks and provide all required day-to-day business management services, including, but not limited to:

●

general administrative support services;

●

information systems;

●

recordkeeping;

●

billing and collection;

●

obtaining and maintaining all federal, state and local licenses, certifications and regulatory permits.

All clinical matters relating to the operation of TIH and the performance of clinical services through the network of providers shall be the sole and exclusive responsibility of the TIH Board free of any control or direction by Catasys.

TIH pays us a monthly fee equal to the aggregate amount of (a) our costs of providing management services (including reasonable overhead allocable to the delivery of our services and including salaries, rent, equipment, and tenant improvements incurred for the benefit of the medical group, provided that any capitalized costs will be amortized over a five-year period), (b) 10%-15% of the foregoing costs, and (c) any performance bonus amount, as determined by the treatment center at its sole discretion. The treatment center’s payment of our fee is subordinate to payment of the treatment center's obligations, including physician fees and medical group employee compensation.

Under the MSA, the equity owner of the affiliated treatment center has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We also agree to provide working capital loans to allow for TIH to pay for its obligations. Substantially all of the activities of TIH either involves us or are conducted for our benefit, as evidenced by the facts that (i) the operations of TIH is conducted primarily using our licensed protocols and (ii) under the MSA, we agree to provide and perform all non-medical management and administrative services for the treatment center. Payment of our management fee is subordinate to payments of the obligations of TIH, and repayment of the working capital loans is not guaranteed by the equity owner of TIH or other third party. Creditors of TIH do not have recourse to our general credit. Based on these facts, we have determined that TIH is a VIE and that we are the primary beneficiary as defined in current accounting rules. Accordingly, we are required to consolidate the assets, liabilities, revenues and expenses of the managed treatment center.

The amounts and classification of assets and liabilities of the VIE included in our consolidated balance sheets at June 30, 2018 are as follows:

(in thousands)	June 30, 2018
Cash and cash equivalents	$	96

Accounts payable		7
Accrued liabilities		50
Total liabilities	$	57

Warrant Liabilities

The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions:

	June 30, 2018
Expected volatility		102.90	%
Risk-free interest rate		2.52	%
Weighted average expected lives in years		1.79
Expected dividend		0	%

We issued 11,049 warrants to purchase common stock in April 2015 which are being accounted for as liabilities in accordance with Financial Accounting Standards Board (“FASB”) accounting rules, due to anti-dilution provisions in the warrants that protect the holders from declines in our stock price, which is considered outside our control. These warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.

For the three and six months ended June 30, 2018, we recognized a loss of $19,000 and $29,000, respectively, compared with a gain of $7.0 million and $1.8 million for the same periods in 2017, respectively, related to the revaluation of our warrant liabilities.

Recently Issued or Newly Adopted Accounting Standards

In June 2018, the FASB issued Accounting Standard Update (“ASU”) 2018-07, Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption is permitted, but no earlier than a company's adoption date of ASC 606. The Company is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606) (“ASU 2016-10”), which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU 2014-09, which is effective for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. We have selected the modified retrospective approach as our transition method under ASU 2016-10 and the financial impact to the financial statements was to decrease retained earnings and deferred revenue by $1.9 million effective January 1, 2018 (Please see footnote 3).

In February 2016, the FASB ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the lease commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (i.e., January 1, 2019, for a calendar year entity). Early application is permitted. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. We are currently evaluating the expected impact that the standard could have on our condensed consolidated financial statements and related disclosures. We plan on having this analysis completed during the fourth quarter of 2018.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (“ASU 2016-13”). The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. We are currently evaluating the impact of the adoption of this standard on our condensed consolidated financial statements and related disclosures.

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”). The amendments in this update are intended to simplify the accounting for certain equity linked financial instruments and embedded features with down round features that result in the strike price being reduced on the basis of the pricing of future equity offerings. Under the new guidance, a down round feature will no longer need to be considered when determining whether certain financial instruments or embedded features should be classified as liabilities or equity instruments. That is, a down round feature will no longer preclude equity classification when assessing whether an instrument or embedded feature is indexed to an entity's own stock. In addition, the amendments clarify existing disclosure requirements for equity-classified instruments. These amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. The adoption of ASU 2017-11 should not have a material impact on our condensed consolidated financial statements.

Note 3. ASC 606

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 - Revenue Recognition (“ASC 605”) and most industry-specific guidance throughout ASC 605. The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures. The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services.

We adopted ASC 606 effective January 1, 2018 using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The cumulative effect of the changes made to our consolidated January 1, 2018 balance sheet for the adoption of ASU 2014-09 were as follows (in thousands):

	Balance at December 31, 2017			Adjustments Due to Adoption of ASC606		Balance at January 1, 2018
Balance Sheet
Liabilities
Deferred revenue	$	(2,914	)	$	1,877	$	(1,037	)

Equity
Retained earnings		(293,324	)		1,877		(291,447	)

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated income statement and balance sheet for the three and six months ended June 30, 2018 was as follows (in thousands):

	Three Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	3,273		$	1,734		$	1,539

Net loss		(4,200	)		(5,739	)		1,539

	Six Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	5,184		$	2,886		$	2,298

Net loss		(8,418	)		(10,716	)		2,298

Note 4. Long-Term Debt

Repayment of the loans is on an interest-only basis through September 1, 2019, followed by monthly payments of principal and accrued interest for the balance of the term, subject to extension in the event the billings of the Company exceed $20.0 million during the six months period ended June 30, 2019. The loans bear interest at a floating coupon rate of 8.75% plus the amount by which one-month LIBOR exceeds 2.0%. We have also agreed to make quarterly revenue based payments to the Lender in the amount of 0.2% of their consolidated revenue in accordance with GAAP, in any quarter in which the Company’s EBITDA is negative, or 0.4% of such consolidated revenue if the Company’s EBITDA is positive. A final payment equal to 6.0% of each loan tranche will be due on the scheduled maturity date of March 1, 2022 for each loan. In addition, if we repay all or a portion of the loan prior to the applicable maturity date, we will pay the Lender a prepayment penalty fee, based on a percentage of the then outstanding principal balance, equal to 3% if the prepayment occurs during the interest-only payment period, 2% thereafter, plus the amount by which the Revenue Based Payments received prior to such prepayment did not exceed certain minimum thresholds. We paid $23,000 in interest for the three and six months ended June 30, 2018.

Obligations under the Loan Agreement are secured by a first priority security interest in all of our respective assets, with the exception of intellectual property. We have agreed not to pledge or otherwise encumber our intellectual property assets, subject to certain exceptions.

The Loan Agreement includes customary affirmative and restrictive covenants, excluding any covenants to attain or maintain certain financial metrics, and also includes customary events of default, including for payment failures, breaches of covenants, change of control and material adverse changes. Upon the occurrence of an event of default and following any applicable cure periods, a default interest rate of an additional 5% may be applied to the outstanding loan balances (and a late payment fee of 6% of the amount due incurred), and the Lender may declare all outstanding obligations immediately due and payable and take such other actions as set forth in the Loan Agreement.

In connection with the Loan Agreement, the Company obligated to pay the Lender a $75,000 commitment fee.

We recognized approximately $438,000 of debt discount associated with this Loan Agreement, which is being amortized to interest expense using the effective interest method over the term of the Loan Agreement. Amortization of the debt discount associated with the Loan Agreement was approximately $4,000 for the three and six months ended June 30, 2018 and is included in interest expense in the accompanying condensed consolidated statements of operations.

Also in June 2018, we entered into a loan and security agreement in connection with a $2.5 million receivables financing facility with Corporate Finance, a division of Heritage Bank of Commerce (the “A/R Facility”). The A/R Facility provides for us to borrow up to 85% of the Company’s eligible accounts receivable, as defined in the A/R Facility. Interest on such borrowings accrues at the rate of the Wall Street Journal Prime Rate plus 3.0%. The lender under the A/R Facility is entitled to an annual facility fee of 1% and the initial term of the A/R Facility is two years. Obligations under the A/R Facility are secured by a first priority security interest in all of the personal property of the Company, with the exception of intellectual property, and are senior to all borrowings under the Loan Agreement pursuant to an intercreditor agreement.

In connection with the A/R Facility agreement, we issued Heritage Bank of Commerce warrants to purchase an aggregate of 9,720 shares of common stock (the “Heritage Warrants”), subject to a reduction in the event of early termination of the AR Facility agreement. These warrants were recorded as debt issuance costs as well as all fees associated with securing the A/R Facility and are being amortized to interest expense over the two-years term of the A/R Facility using the straight-line method. We recognized approximately $248,000 of debt issuance costs associated with the A/R Facility, and the amortization of the debt issuance costs associated with the A/R Facility was approximately $6,000 for the three and six months ended June 30, 2018 and is included in interest expense in the accompanying condensed consolidated statements of operations.

Note 5. Subsequent Events

In August 2018, at our Annual Stockholders Meeting, Stockholders approved an amendment to the Company's 2017 Stock Incentive Plan, among other things, to provide for an additional 1,400,000 shares to be issued in connection with awards granted thereunder.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements, including the related notes, and the other financial information included elsewhere in this report. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included elsewhere in this report and our annual report filed on Form 10-K for the year ended December 31, 2017.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION

This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations, business strategies, operating efficiencies or synergies, competitive positions, growth opportunities for existing products, plans and objectives of management, markets for our stock and other matters. Statements in this report that are not historical facts are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 21E of the Exchange Act of 1934, as amended (the “Exchange Act”) and Section 27A of the Securities Act of 1933, as amended. Such forward-looking statements, including, without limitation, those relating to the future business prospects, our revenue and income, wherever they occur, are necessarily estimates reflecting the best judgment of our senior management as of the date on which they were made, or if no date is stated, as of the date of this report. These forward-looking statements are subject to risks, uncertainties and assumptions, including those described in the “Risk Factors” in Item 1A of Part I of our most recent Annual Report on Form 10-K (“Form 10-K”) for the fiscal year ended December 31, 2017 and other reports we filed with the Securities and Exchange Commission (“SEC”), that may affect the operations, performance, development and results of our business. Because the factors discussed in this report could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any such forward-looking statements. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We assume no obligation and do not intend to update these forward looking statements, except as required by law.

OVERVIEW

General

Our OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions. We have a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven motivational and consumer engagement technologies.

OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 54 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin.

Recent Developments

Debt Financing

In connection with the Loan Agreement, the Company obligated to pay the Lender a $75,000 commitment fee.

Operations

We currently operate our OnTrak solutions in California, Connecticut, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. We provide services to commercial (employer funded), managed Medicare Advantage, and managed Medicaid and dual eligible (Medicare and Medicaid) populations. We have generated fees from our launched programs and expect to launch additional customers and increase enrollment and fees throughout 2018. However, there can be no assurance that we will generate such fees or that new programs will launch as we expect.

RESULTS OF OPERATIONS

Table of Summary Consolidated Financial Information

The table below and the discussion that follows summarize our results of consolidated operations for the three and six months ended June 30, 2018 compared to the three and six months ended June 30, 2017:

	Three Months Ended						Six Months Ended
(In thousands, except per share amounts)	June 30,						June 30,
	2018			2017			2018			2017
Revenues
Healthcare services revenues	$	3,273		$	1,665		$	5,184		$	3,487

Operating expenses
Cost of healthcare services		2,941			1,332			5,228			2,697
General and administrative		4,392			2,940			8,178			5,569
Depreciation and amortization		85			45			170			84
Total operating expenses		7,418			4,317			13,576			8,350

Loss from operations		(4,145	)		(2,652	)		(8,392	)		(4,863	)

Other income		-			14			40			28
Interest expense		(36	)		(539	)		(37	)		(3,406	)
Loss on conversion of note		-			(430	)		-			(1,356	)
Loss on issuance of common stock		-			(145	)		-			(145	)
Change in fair value of warrant liability		(19	)		6,950			(29	)		1,769
Change in fair value of derivative liability		-			10,728			-			132
Income/(Loss) from operations before provision for income taxes		(4,200	)		13,926			(8,418	)		(7,841	)
Provision for income taxes		-			1			-			2
Net Income/(Loss)	$	(4,200	)	$	13,925		$	(8,418	)	$	(7,843	)

Summary of Consolidated Operating Results

Loss from operations before provision for income taxes for the three months ended June 30, 2018 was $4.2 million and loss from operations before provision for income taxes for the six months ended June 30, 2018 was $8.4 million, compared with a net income of $13.9 million and net loss of $7.8 million for the same periods in 2017, respectively. The difference primarily relates to the decrease in interest expense, the decrease in the loss on conversion of note, the decrease in the loss from change in fair value of warrant liability, and the decrease in the loss from change in fair value of the derivative liability for the three and six months ended June 30, 2018, compared to the same period in 2017.

Revenues

During the six months ended June 30, 2018, we have launched enrollment with three new health plans in Illinois, Tennessee and California, expanded with two of our current health plans and have continued to increase enrollment, which has resulted in a net increase in the number of patients enrolled in our OnTrak solutions compared with the same period in 2017, this was offset by the timing of billing for certain members who we bill on a per claim basis. For the six months ended June 30, 2018 net enrollment increased by approximately 149% over the same period in 2017. Recognized revenue increased by $1.6 million and $1.7 million, or 97% and 49%, for the three and six months ended June 30, 2018, compared with the same periods in 2017, respectively.

Cost of Healthcare Services

Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists, healthcare provider claims payments to our network of physicians and psychologists, and fees charged by our third party administrators for processing these claims. The increase of $1.6 million and $2.5 million for the three and six months ended June 30, 2018, compared with the same periods in 2017, respectively, relates primarily to the increase in members being treated, the addition of care coaches, outreach specialists, community care coordinators and other staff to manage the increasing number of enrolled members. In addition, we hire staff in preparation for anticipated future customer contracts and corresponding increases in members eligible for OnTrak.

General and Administrative Expenses

Total general and administrative expense increased by $1.5 million and $2.6 million for the three and six months ended June 30, 2018, compared with the same periods in 2017. The increase in general and administrative expenses was primarily related to investments in data science, IT and software development to support growth and drive efficiency. In addition, there was an increase of approximately $594,000 in non-cash share-based compensation expense during the first six months of 2018 related to the issuance of stock options in the fourth quarter of 2017 which are being amortized over the related vesting periods.

Interest Expense

Interest expense decreased by $503,000 and $3.4 million for the three months and six months ended June 30, 2018 compared with the same periods in 2017. The decrease relates to the issuance of our convertible debentures and warrants issued in connection with those convertible debentures in the 2017 period. The majority of these instruments were either converted to equity or paid in full in April 2017 and as a result there was no significant expense for the three and six months ended June 30, 2018.

Loss of conversion of note

Loss on conversion of note relates to the conversion of a portion of the December 2016 Convertible Debentures for the three and six months ended June 30, 2017. No such conversion occurred for the same period during 2018.

Change in fair value of warrant liability

We have issued 11,049 warrants to purchase common stock in April 2015 which are being accounted for as liabilities in accordance with FASB accounting rules, due to anti-dilution provisions in the warrants that protect the holders from declines in our stock price and a requirement to deliver registered shares upon exercise of the warrants, which is considered outside our control. The warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.

The decrease in the loss from change in fair value for the warrants was $7.0 and $1.8 million for the three and six months ended June 30, 2018 compared with the same period in 2017.

In April 2017, we removed the anti-dilution protection in most of our warrants. We will continue to mark-to-market the remaining 11,049 warrants with anti-dilution protection to market value each quarter-end until they are completely settled or expire.

Change in fair value of derivative liability

The decrease in the loss from change in fair value of derivative liabilities was $10.7 million and $132,000 for the three and six months ended June 30, 2018, respectively, compared with the same periods in 2017. The derivative liability was the result of the issuance of the July 2015 Convertible Debenture, which was converted into 2,385,111 shares of common stock in April 2017.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

As of August 13, 2018, we had a balance of approximately $5.3 million cash on hand. We had a working capital deficit of $657,000 as of June 30, 2018. We have incurred significant operating losses and negative operating cash flows since our inception. We could continue to incur negative cash flows and operating losses for the next twelve months. Our second quarter average cash burn rate is approximately $234,000, which is reduction of over $900,000 from our average burn rate from the first quarter of 2018. In June 2018, we closed on a debt offering for aggregate net proceeds of $4.9 million. We expect our current cash resources to cover expenses through at least the next twelve months, however, delays in cash collections, revenue, or unforeseen expenditures could impact this estimate.

Cash Flows

We used $3.8 million of cash from operating activities during the six months ended June 30, 2018 compared with $3.2 million in the same period in 2017. The increase in cash used in operating activities reflects the increase in the number of enrolled members and the addition of staff in preparation for anticipated future increases in members eligible for OnTrak.

There was no capital expenditures for the six months ended June 30, 2018. We anticipate that capital expenditures will increase in the future as we replace our computer systems that are reaching the end of their useful lives, upgrade equipment to support our increased number of enrolled members and enhance the reliability and security of our systems. These future capital expenditure requirements will depend upon many factors, including obsolescence or failure of our systems, progress with expanding the adoption of our solutions, our marketing efforts, the necessity of, and time and costs involved in obtaining, regulatory approvals, competing technological and market developments, and our ability to establish collaborative arrangements, effective commercialization, marketing activities and other arrangements.

Our net cash provided by financing activities was $4.7 million for the six months ended June 30, 2018, compared with net cash provided by financing activities of $11.7 million for the six months ended June 30, 2017, respectively. Cash provided by financing activities for the six months ended June 30, 2018 consisted of the gross proceeds from the issuance of debt in the amount of $5.0 million, offset by debt issuance costs of $324,000, and capital lease obligations of $18,000 leaving a balance of $5.6 million in cash and cash equivalents at June 30, 2018.

As discussed above, our second quarter average cash burn rate is approximately $234,000, which is reduction of over $900,000 from our average burn rate from the first quarter of 2018. We also anticipate cash inflow to increase during 2018 as we continue to service our executed contracts and sign new contracts. We expect our current cash resources to cover our operations through at least the next twelve months; however, delays in cash collections, revenue, or unforeseen expenditures could impact this estimate.

OFF BALANCE SHEET ARRANGEMENTS

As of June 30, 2018, we had no off-balance sheet arrangements.

CRITICAL ACCOUNTING ESTIMATES

The discussion and analysis of our financial condition and results of operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. We base our estimates on experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that may not be readily apparent from other sources. On an on-going basis, we evaluate the appropriateness of our estimates and we maintain a thorough process to review the application of our accounting policies. Our actual results may differ from these estimates.

We consider our critical accounting estimates to be those that (1) involve significant judgments and uncertainties, (2) require estimates that are more difficult for management to determine, and (3) may produce materially different results when using different assumptions. We have discussed these critical accounting estimates, the basis for their underlying assumptions and estimates and the nature of our related disclosures herein with the audit committee of our Board of Directors. We believe our accounting policies related to revenue recognition and share-based compensation expense, involve our most significant judgments and estimates that are material to our consolidated financial statements. They are discussed further below.

Revenue Recognition

In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 - Revenue Recognition (“ASC 605”) and most industry-specific guidance throughout ASC 605. The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures. The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services.

	Balance at December 31, 2017			Adjustments Due to Adoption of ASC606		Balance at January 1, 2018
Balance Sheet
Liabilities
Deferred revenue	$	(2,914	)	$	1,877	$	(1,037	)

Equity
Retained earnings		(293,324	)		1,877		(291,447	)

	Three Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	3,273		$	1,734		$	1,539

Net loss		(4,200	)		(5,739	)		1,539

	Six Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	5,184		$	2,886		$	2,298

Net loss		(8,418	)		(10,716	)		2,298

Share-based compensation expense

We account for the issuance of stock, stock options, and warrants for services from non-employees based on an estimate of the fair value of options and warrants issued using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the option or warrant, expected volatility of our stock and expected dividend yield.

The amounts recorded in the financial statements for share-based compensation expense could vary significantly if we were to use different assumptions. For example, the assumptions we have made for the expected volatility of our stock price have been based on the historical volatility of our stock, measured over a period generally commensurate with the expected term. If we were to use a different volatility than the actual volatility of our stock price, there may be a significant variance in the amounts of share-based compensation expense from the amounts reported. The weighted average expected option term for the six months ended June 30, 2018 and 2017, reflects the application of the simplified method set out in SEC Staff Accounting Bulletin No. 107, which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.

From time to time, we retain terminated employees as part-time consultants upon their resignation from the Company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no longer accounted for as employee awards and are accounted for as new non-employee awards. The accounting for the portion of the total grants that have already vested and have been previously expensed as equity awards is not changed. There were no employees moved to consulting status for the three and six months ended June 30, 2018 and 2017, respectively.

RECENT ACCOUNTING PRONOUNCEMENTS

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Disclosure Controls

We have evaluated, with the participation of our principal executive officer and our principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of June 30, 2018. Based on this evaluation, our principal executive officer and our principal financial officer have concluded that, as of June 30, 2018, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal controls over financial reporting during the three months ended June 30, 2018, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

None.

Item 1A.

Risk Factors

None.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

In June 2018, in connection with our entry into the Facility Agreement, we issued Heritage warrants to purchase an aggregate of 9,720 shares of common stock (the “Heritage Warrants”), subject to reduction in the event of early termination of the Facility Agreement. The per share exercise price of the Heritage Warrants is $7.7159.

The Heritage Warrants have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or the securities laws of any state, and were offered and issued in reliance on the exemption from registration under the Securities Act, provided by Section 4(a)(2) under the Securities Act.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None

Item 6.

Exhibits

Exhibit 4.1	Form of Heritage Warrant, incorporated by reference to Exhibit 4.1 of Catasys, Inc.’s Form 8-K filed with the Securities and Exchange Commission on June 15, 2018.
Exhibit 10.1	Loan and Security Agreement, dated June 14, 2018, by and between Catasys, Inc. and Corporate Finance, a division of Heritage Bank of Commerce, incorporated by reference to Exhibit 10.1 of Catasys, Inc.’s, Form 8-K, filed with the Securities and Exchange Commission on June 15, 2018.
Exhibit 10.2	Venture Loan and Security Agreement, dated June 14, 2018, by and between Catasys, Inc. and Horizon Technology Finance Corporation, incorporated by reference to Catasys, Inc.’s Form 8-K filed with the Securities and Exchange Commission on June 15, 2018.
Exhibit 31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1**	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 32.2**	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*	XBRL Instance
101.SCH*	XBRL Taxonomy Extension Schema
101.CAL*	XBRL Taxonomy Extension Calculation
101.DEF*	XBRL Taxonomy Extension Definition
101.LAB*	XBRL Taxonomy Extension Labels
101.PRE*	XBRL Taxonomy Extension Presentation

* filed herewith.

** furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CATASYS, INC.


Date: August 14, 2018	By:	/s/ TERREN S. PEIZER
		Terren S. Peizer
		Chief Executive Officer (Principal Executive Officer)


Date: August 14, 2018	By:	/s/ CHRISTOPHER SHIRLEY
		Christopher Shirley
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-31.1 2 ex_121337.htm EXHIBIT 31.1 ex_121337.htm

Exhibit 31.1

CERTIFICATION

I, Terren S. Peizer, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Catasys, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2018	/s/ TERREN S. PEIZER
	Terren S. Peizer
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2 3 ex_121338.htm EXHIBIT 31.2 ex_121338.htm

Exhibit 31.2

CERTIFICATION

I, Christopher Shirley, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Catasys, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2018	/s/ CHRISTOPHER SHIRLEY
	Christopher Shirley
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1 4 ex_121339.htm EXHIBIT 32.1 ex_121339.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Catasys, Inc. (the “Company) for the quarter ended June 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report), I, Terren S. Peizer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ TERREN S. PEIZER		August 14, 2018
Terren S. Peizer		Date
Chief Executive Officer
(Principal Executive Officer)

EX-32.2 5 ex_121340.htm EXHIBIT 32.2 ex_121340.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Catasys, Inc. (the “Company) for the quarter ended June 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report), I, Christopher Shirley, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ CHRISTOPHER SHIRLEY		August 14, 2018
Christopher Shirley		Date
Chief Financial Officer
(Principal Financial and Accounting Officer)

EX-101.INS 6 cats-20180630.xml XBRL INSTANCE DOCUMENT 468750 63000 63000 0 24000 90000 9720 90000 233734 0.02 5000000 5000000 20000000 2.50 0.06 0.05 0.06 0.02 0.03 0.002 0.004 1100000 -1400000 -430000 -1356000 -83807 -145000 -145000 0.85 5 3 2 0.66 0.63 0.34 0.37 1 1 4.464 7163000 1122000 59000 30000 59000 63000 false --12-31 Q2 2018 2018-06-30 10-Q 0001136174 15913171 Yes Smaller Reporting Company CATASYS, INC. No No cats

7000

1215000

980000

50000

1688000

1542000

295234000

294220000

753000

86000

476000

4000

6000

10000

3335000

4571912

2255381

7896000

6604000

6944000

5656000

71000

2000

96000

5603000

4779000

851000

9222000

71000

824000

8371000

5400000

11049

9720

2045248

2011528

0.0001

500000000

15913171

15889171

15913171

15889171

15913171

2000

0.93

0.26

0.25

0.16

0.15

0.11

0.71

0.42

0.17

0.12

0.36

0.19

0.17

-1877000

3416000

2914000

1037000

2941000

1332000

5228000

2697000

1877000

2982994

0.03

7.50

75000

0.0875

P2Y

434000

438000

248000

25000

85000

45000

170000

84000

170000

84000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended<br /> June 30, 2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended<br /> June 30, 2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Revenue</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Percentage</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Revenue</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Percentage</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Commercial</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,145</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,245</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Government</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,939</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,273</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,184</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table></div>

-0.26

-0.53

-0.68

-0.26

0.97

-0.53

-0.68

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Basic and Diluted </div><div style="display: inline; font-weight: bold;">Income (</div><div style="display: inline; font-weight: bold;">Loss</div><div style="display: inline; font-weight: bold;">)</div><div style="display: inline; font-weight: bold;"> per Share</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Basic income (loss) per share is computed by dividing the net loss to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss for the period by the weighted average number of common stock and dilutive common equivalent shares outstanding during the period.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Common equivalent shares, consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,571,912</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,255,381</div> common shares for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Common equivalent shares, consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,701</div> incremental common shares for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017, </div>issuable upon the exercise of warrants have been included in the diluted earnings per share calculation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div> <table style="margin-right: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 18pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">(in thousands, except per share amounts)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Numerator</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Net income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,200</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,925</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,418</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,843</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Denominator</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Weighted-average common shares outstanding</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,885</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares used in calculation - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,885</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares issuable for stock options and warrants</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">414</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares used in calculation - diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,299</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net income (loss) per share from operations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.26</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.53</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.68</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.26</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.97</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.53</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.68</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;" nowrap="nowrap">)</td> </tr> </table> </div></div></div></div></div></div>

1403000

1177000

6700000

P3Y182D

19000

29000

-6950000

-1769000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 7.5%; margin-left: 7.5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 82%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div><div style="display: inline; font-weight: bold;">, 201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Expected volatility</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102.90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.52</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average expected lives in years</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.79</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Expected dividend</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> </table></div>

29000

30000

59000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Fair Value Measurements</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> levels of the fair value hierarchy are described below:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><div style="display: inline; font-weight: bold;"> </div></div> <table style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt auto 0pt 36pt; min-width: 700px;" cellspacing="0pt" cellpadding="0pt" border="0px"> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Level Input:</div></div> </td> <td style="vertical-align: bottom; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Input Definition:</div></div> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Level I</div> </td> <td style="vertical-align: top; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: top; border-bottom: 1px rgb(0, 0, 0); width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</div> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Level II</div> </td> <td style="vertical-align: top; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: top; width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</div> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Level III</div> </td> <td style="vertical-align: top; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: top; width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The following table summarizes fair value measurements by level at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>for assets and liabilities measured at fair value:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;"> </div> <div> <table style="margin-right: 5%; margin-left: 5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at June 30, 2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(Amounts in thousands)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level I</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level II</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level III</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certificates of deposit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">Total assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Warrant liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">Total liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Financial instruments classified as Level III in the fair value hierarchy as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>represent our liabilities measured at market value on a recurring basis which include warrant liabilities resulting from recent debt financings. In accordance with current accounting rules, the warrant liabilities with anti-dilution protection are being marked-to-market each quarter-end until they are completely settled or expire. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See <div style="display: inline; font-style: italic;">Warrant Liabilities</div> below.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018:</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level III</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Warrant </div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(Dollars in thousands)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Balance as of December 31, 2017</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left;">Issuance of warrants</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left;">Change in fair value</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Balance as of June 30, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div></div></div></div></div></div>

-68000

4392000

2940000

8178000

5569000

-4200000

13926000

-8418000

-7841000

1000

2000

40000

1486000

164000

629000

169000

2379000

843000

-45000

-39000

-165000

-242000

413701

36000

539000

37000

3406000

23000

86000

112000

181000

57000

12525000

5706000

7896000

6604000

7601000

5649000

59000

0.01

2500000

4865000

4658000

11707000

-127000

-3834000

-3209000

-4200000

13925000

-8418000

-7843000

-5739000

1539000

-10716000

2298000

-8418000

7418000

4317000

13576000

8350000

-4145000

-2652000

-8392000

-4863000

1567000

578000

336000

14000

40000

28000

1667000

324000

127000

0.0001

50000000

201000

366000

15000000

1500000

16458000

5000000

1300000

374000

612000

P2Y

P7Y

P5Y

P7Y

234000

1140000

511000

4363000

18000

21000

1877000

-299865000

-293324000

-291447000

3273000

1665000

5184000

3487000

2145000

3245000

1128000

1939000

1734000

1539000

2886000

2298000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 18pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">(in thousands, except per share amounts)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Numerator</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Net income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,925</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,843</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Denominator</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Weighted-average common shares outstanding</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares used in calculation - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares issuable for stock options and warrants</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">414</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares used in calculation - diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,299</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net income (loss) per share from operations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at June 30, 2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(Amounts in thousands)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level I</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level II</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level III</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certificates of deposit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">Total assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Warrant liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">Total liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 36pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 49%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments Due</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">to Adoption of</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">ASC606</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">January 1, 2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Balance Sheet</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Deferred revenue</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,914</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,877</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,037</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 49%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Equity</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Retained earnings</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(293,324</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,877</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(291,447</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 54pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 49%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended June 30, 2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 49%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As<br /> Reported</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balances Without Adoption of<br /> ASC 606</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Effect of Change </div><br /> Higher/(Lower)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Income Statement</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Revenues</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Healthcare services revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,273</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,734</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,539</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 49%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net loss</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,739</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,539</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 54pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 49%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended June 30, 2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 49%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As<br /> Reported</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balances Without Adoption of<br /> ASC 606</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Effect of Change </div><br /> Higher/(Lower)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Income Statement</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Revenues</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Healthcare services revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,184</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,886</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,298</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 49%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 49%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net loss</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,716</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,298</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

425000

753000

32000

159000

753000

159000

P3Y

P5Y

1400000

2333334

243853

50523

1026

642307

2526664

1885383

2526664

11.46

10.24

546.19

7.50

P10Y

368609

4.80

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> <div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Summary of Significant Accounting Policies</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Revenue Recognition</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;">      Revenue from contracts with customers is recognized when, or as, we satisfy our performance obligations by transferring the promised goods or services to the customers. A good or service is transferred to a customer when, or as, the customer obtains control of that good or service. A performance obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be satisfied over time or at a point in time. Revenue from a performance obligation satisfied over time is recognized by measuring our progress in satisfying the performance obligation in a manner that depicts the transfer of the goods or services to the customer. Revenue from a performance obligation satisfied at a point in time is recognized at the point in time that we determine the customer obtains control over the promised good or service. The amount of revenue recognized reflects the consideration we expect to be entitled to in exchange for those promised goods or services (<div style="display: inline; font-style: italic;">i.e.</div>, the “transaction price”). In determining the transaction price, we consider multiple factors, including the effects of variable consideration. Variable consideration is included in the transaction price only to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> occur when the uncertainties with respect to the amount are resolved. In determining when to include variable consideration in the transaction price, we consider the range of possible outcomes, the predictive value of our past experiences, the time period of when uncertainties expect to be resolved and the amount of consideration that is susceptible to factors outside of our influence, such as the judgment and actions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> parties.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:28.5pt;">The following table disaggregates our revenue by contract (in thousands):</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended<br /> June 30, 2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended<br /> June 30, 2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Revenue</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Percentage</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Revenue</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Percentage</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Commercial</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,145</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,245</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Government</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,939</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 36%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,273</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,184</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:28.5pt;">Because the Company’s contracts have an expected duration of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less, the Company has elected the practical expedient in Accounting Standards Codification (“ASC”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div>(a) to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> disclose information about its remaining performance obligations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:28.5pt;">Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis, an upfront case rate, or fee for service based on enrolled members. The Company’s performance obligation is satisfied over time as the On<div style="display: inline; font-style: italic;">Trak</div> service is provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing a continuous service to the customer. Contracts with minimum performance guarantees or price concessions include variable consideration and are subject to the revenue constraint. The Company uses an expected value method to estimate variable consideration for minimum performance guarantees and price concessions. The Company has constrained revenue for expected price concessions during the period ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Cost of Services</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party administrators for processing these claims. Salaries and fees charged by our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div><div style="display: inline; font-style: italic;"> </div>party administrators for processing claims are expensed when incurred and healthcare provider claims payments are recognized in the period in which an eligible member receives services. We contract with doctors and licensed behavioral healthcare professionals, on a fee-for-service basis. We determine that a member has received services when we receive a claim or in the absence of a claim, by utilizing member data recorded in the On<div style="display: inline; font-style: italic;">Trak</div><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline;">TM </div>database within the contracted timeframe, with all required billing elements correctly completed by the service provider. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Cash Equivalents and Concentration of Credit Risk</div><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">We consider all highly liquid investments with an original maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents. Cash is deposited with what we believe are highly credited, quality financial institutions. The deposited cash <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>we had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.4</div> million in cash and cash equivalents exceeding federally insured limits.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">93%</div> of revenues (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div>) and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71%</div> of accounts receivable (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div>).</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36%</div> of revenues (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div>).</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Basic and Diluted </div><div style="display: inline; font-weight: bold;">Income (</div><div style="display: inline; font-weight: bold;">Loss</div><div style="display: inline; font-weight: bold;">)</div><div style="display: inline; font-weight: bold;"> per Share</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Basic income (loss) per share is computed by dividing the net loss to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss for the period by the weighted average number of common stock and dilutive common equivalent shares outstanding during the period.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Common equivalent shares, consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,571,912</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,255,381</div> common shares for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Common equivalent shares, consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,701</div> incremental common shares for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017, </div>issuable upon the exercise of warrants have been included in the diluted earnings per share calculation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 18pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">(in thousands, except per share amounts)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Numerator</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Net income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,925</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,843</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Denominator</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Weighted-average common shares outstanding</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares used in calculation - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares issuable for stock options and warrants</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">414</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shares used in calculation - diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,913</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,299</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net income (loss) per share from operations</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 45pt; text-align: left;">Diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Share-Based Compensation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Stock Incentive Plan (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2017</div> Plan”), provides for the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,333,334</div> shares of our common stock and an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">243,853</div> shares of our common stock that are represented by awards granted under our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> Stock Incentive Plan (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2010</div> Plan”). Incentive stock options (ISOs) under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">422A</div> of the Internal Revenue Code and non-qualified options (NSOs) are authorized under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Plan. We have granted stock options to executive officers, employees, members of our board of directors, and certain outside consultants. The terms and conditions upon which options become exercisable vary among grants, but option rights expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> later than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years from the date of grant and employee and board of director awards generally vest over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>we had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,526,664</div> shares outstanding, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">368,609</div> shares are vested and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,523</div> shares are available for future awards under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Plan.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Share-based compensation expense attributable to operations were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$425,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$753,000</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>respectively compared with approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$32,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$159,000</div> for the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Stock Options – Employees and Directors</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our consolidated statements of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> is based on awards ultimately expected to vest, reduced for estimated forfeitures. Accounting rules for stock options require forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">642,307</div> options granted to employees and directors during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>compared with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> options granted during the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Employee and director stock option activity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>are as follows:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted Avg.</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise Price</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Balance December 31, 2017</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,885,383</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 62%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">642,307</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Cancelled</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,026</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">546.19</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 62%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Balance June 30, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,526,664</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.24</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> reflects the application of the simplified method prescribed in Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">107</div> (as amended by SAB <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110</div>), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.7</div> million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Plan. That cost is expected to be recognized over a weighted-average period of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.5</div> years.          </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Stock Options and Warrants – Non-employees</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> options issued to non-employees for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>or in the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> share-based compensation expense relating to stock options and warrants recognized for non-employees for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>or in the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24,000</div> warrants issued in exchange for services during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>compared with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div> options issued in exchange for services during the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Generally, the costs associated with warrants issued for services are amortized to the related expense on a straight-line basis over the related service periods.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,720</div> warrants issued in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2018 </div>A/R Facility financing (see Footnote <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>).</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,045,248</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,011,528</div> warrants outstanding as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;text-indent:18pt;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Common Stock</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24,000</div> shares of common stock issued in exchange for investor relations services during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>respectively, compared with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,493</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,985</div> for the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Generally, the costs associated with shares issued for services are amortized to the related expense on a straight-line basis over the related service periods.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2017, </div>we entered into an underwriting agreement with Joseph Gunnar & Co., LLC (“Joseph Gunnar”), as underwriter in connection with a public offering of the Company’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,125,000</div> shares of common stock at a public offering price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.80</div> per share, and the purchase price to the underwriter after discounts and commission was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.464</div> per share. The closing of the offering occurred on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 28, 2017. </div>We received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15.0</div> million in gross proceeds in connection with the offering.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45</div> day over-allotment option to purchase up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">468,750</div> additional shares of common stock at the public offering price less the applicable underwriter discount. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May, </div>the underwriter acquired an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">303,750</div> shares pursuant to such over-allotment option. We received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.5</div> million in gross proceeds in connection with the over-allotment option.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 26, 2017.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2017, </div>several investors, including Acuitas Group Holdings, LLC (“Acuitas”), <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one hundred</div> percent (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div>) of which is owned by Terren S. Peizer, Chairman and Chief Executive Officer of the Company, and Shamus, LLC (“Shamus”), a Company owned by David E. Smith, a member of our board of directors, exercised their option to convert their convertible debentures and received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,982,994</div> shares of common stock. There was a loss on the conversion of the convertible debentures of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.4</div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2017, </div>Terren S. Peizer agreed to settle his deferred salary balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div> million for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">233,734</div> shares of common stock. As a result, the Company recognized a loss on settlement of liability totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$83,807</div> which is recorded to loss on issuance of common stock.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2017, </div>we filed a certificate of amendment to our Certificate of Incorporation, as amended and in effect, with the Secretary of State of the State of Delaware, implementing a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>-for-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> reverse stock split of the Company's common stock, pursuant to which each <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> shares of issued and outstanding common stock converted into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> share of common stock. Proportionate voting rights and other rights of common stock holders were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> affected by the reverse stock split.  <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> fractional shares of common stock were issued as a result of the reverse stock split; stockholders were paid cash in lieu of any such fractional shares.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">All stock options and warrants to purchase common stock outstanding and our Common Stock reserved for issuance under the Company's equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> and, as applicable, multiplying the exercise price by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> as a result of the reverse stock split.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Income Taxes</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018.  </div>As such, we have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recorded a provision for income tax for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018.  </div>We utilize the liability method of accounting for income taxes as set forth in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740,</div> Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that some of the deferred tax assets will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be realized. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likelihood that a tax benefit will be sustained, we have recorded the largest amount of tax benefit that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likelihood that a tax benefit will be sustained, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> tax benefit has been recognized in the financial statements.  Based on management's assessment of the facts, circumstances and information available, management has determined that all of the tax benefits for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>should be realized.   </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Fair Value Measurements</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> levels of the fair value hierarchy are described below:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><div style="display: inline; font-weight: bold;"> </div></div> <table border="0px" cellpadding="0pt" cellspacing="0pt" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt auto 0pt 36pt; min-width: 700px;"> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Level Input:</div></div> </td> <td style="vertical-align: bottom; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Input Definition:</div></div> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Level I</div> </td> <td style="vertical-align: top; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: top; border-bottom: 1px rgb(0, 0, 0); width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</div> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Level II</div> </td> <td style="vertical-align: top; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: top; width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</div> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 16.1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Level III</div> </td> <td style="vertical-align: top; width: 3.5%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="vertical-align: top; width: 80.4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The following table summarizes fair value measurements by level at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>for assets and liabilities measured at fair value:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at June 30, 2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(Amounts in thousands)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level I</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level II</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level III</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certificates of deposit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">Total assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 44%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 44%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Warrant liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">Total liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Financial instruments classified as Level III in the fair value hierarchy as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>represent our liabilities measured at market value on a recurring basis which include warrant liabilities resulting from recent debt financings. In accordance with current accounting rules, the warrant liabilities with anti-dilution protection are being marked-to-market each quarter-end until they are completely settled or expire. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See <div style="display: inline; font-style: italic;">Warrant Liabilities</div> below.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018:</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level III</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Warrant </div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(Dollars in thousands)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Balance as of December 31, 2017</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left;">Issuance of warrants</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left;">Change in fair value</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Balance as of June 30, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Property and Equipment</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years for furniture and equipment. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the related lease term, which is typically <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Variable Interest Entities</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Generally, an entity is defined as a Variable Interest Entity (“VIE”) under current accounting rules if it has (a) equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support from other parties, or (b) equity investors that cannot make significant decisions about the entity’s operations, or that do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> absorb the expected losses or receive the expected returns of the entity. When determining whether an entity that is a business qualifies as a VIE, we also consider whether (i) we participated significantly in the design of the entity, (ii) we provided more than half of the total financial support to the entity, and (iii) substantially all of the activities of the VIE either involve us or are conducted on our behalf. A VIE is consolidated by its primary beneficiary, which is the party that absorbs or receives a majority of the entity’s expected losses or expected residual returns.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">As discussed under the heading<div style="display: inline; font-style: italic;"> Management Services Agreement </div>(“MSA”) below, we have an MSA with a Texas nonprofit health organization (“TIH”). Under this MSA, the equity owner of TIH has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We participate significantly in the design of this MSA. We also agree to provide working capital loans to allow for TIH to pay for its obligations. Substantially all of the activities of TIH either involve us or are conducted for our benefit, as evidenced by the facts that (i) the operations of the TIH are conducted primarily using our licensed network of providers and (ii) under the MSA, we agree to provide and perform all non-medical management and administrative services for the medical group. Payment of our management fee is subordinate to payments of the obligations of TIH, and repayment of the working capital loans is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> guaranteed by the equity owner of the affiliated medical group or other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party. Creditors of TIH do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have recourse to our general credit.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Based on the design and provisions of this MSA and the working capital loans provided to the medical group, we have determined that TIH is a VIE, and that we are the primary beneficiary as defined in the current accounting rules. Accordingly, we are required to consolidate the revenues and expenses of the managed medical corporation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Management Services Agreement</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2018, </div>we executed an MSA with TIH. Under the MSA, we license to TIH the right to use our proprietary treatment programs and related trademarks and provide all required day-to-day business management services, including, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="vertical-align:middle;width:3.8%;"> </td> <td style="vertical-align:top;width:3.8%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">● </div> </td> <td style="vertical-align:top;width:92.3%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">general administrative support services;</div> </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="vertical-align:middle;width:3.8%;"> </td> <td style="vertical-align:top;width:3.8%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">● </div> </td> <td style="vertical-align:top;width:92.3%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">information systems;</div> </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="vertical-align:middle;width:3.8%;"> </td> <td style="vertical-align:top;width:3.8%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">● </div> </td> <td style="vertical-align:top;width:92.3%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">recordkeeping;</div> </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="vertical-align:middle;width:3.8%;"> </td> <td style="vertical-align:top;width:3.8%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">● </div> </td> <td style="vertical-align:top;width:92.3%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">billing and collection;</div> </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="vertical-align:middle;width:3.8%;"> </td> <td style="vertical-align:top;width:3.8%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">● </div> </td> <td style="vertical-align:top;width:92.3%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">obtaining and maintaining all federal, state and local licenses, certifications and regulatory permits.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">All clinical matters relating to the operation of TIH and the performance of clinical services through the network of providers shall be the sole and exclusive responsibility of the TIH Board free of any control or direction by Catasys.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">TIH pays us a monthly fee equal to the aggregate amount of (a) our costs of providing management services (including reasonable overhead allocable to the delivery of our services and including salaries, rent, equipment, and tenant improvements incurred for the benefit of the medical group, provided that any capitalized costs will be amortized over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year period), (b) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%</div> of the foregoing costs, and (c) any performance bonus amount, as determined by the treatment center at its sole discretion. The treatment center’s payment of our fee is subordinate to payment of the treatment center's obligations, including physician fees and medical group employee compensation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">Under the MSA, the equity owner of the affiliated treatment center has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We also agree to provide working capital loans to allow for TIH to pay for its obligations. Substantially all of the activities of TIH either involves us or are conducted for our benefit, as evidenced by the facts that (i) the operations of TIH is conducted primarily using our licensed protocols and (ii) under the MSA, we agree to provide and perform all non-medical management and administrative services for the treatment center. Payment of our management fee is subordinate to payments of the obligations of TIH, and repayment of the working capital loans is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> guaranteed by the equity owner of TIH or other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party. Creditors of TIH do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have recourse to our general credit. Based on these facts, we have determined that TIH is a VIE and that we are the primary beneficiary as defined in current accounting rules.  Accordingly, we are required to consolidate the assets, liabilities, revenues and expenses of the managed treatment center.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The amounts and classification of assets and liabilities of the VIE included in our consolidated balance sheets at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>are as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">(in thousands)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Cash and cash equivalents</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">96</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 81%;"> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accounts payable</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accrued liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 9pt;">Total liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Warrant Liabilities</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 7.5%; margin-left: 7.5%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 82%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30</div><div style="display: inline; font-weight: bold;">, 201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Expected volatility</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102.90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.52</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average expected lives in years</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.79</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 82%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Expected dividend</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">We issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,049</div> warrants to purchase common stock in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2015</div><div style="display: inline; font-style: italic;"> </div>which are being accounted for as liabilities in accordance with Financial Accounting Standards Board (“FASB”) accounting rules, due to anti-dilution provisions in the warrants that protect the holders from declines in our stock price, which is considered outside our control.  These warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>we recognized a loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,000,</div> respectively, compared with a gain of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.8</div> million for the same periods in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively, related to the revaluation of our warrant liabilities.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Recently Issued or Newly Adopted Accounting Standards</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2018, </div>the FASB issued Accounting Standard Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07,</div> <div style="display: inline; font-style: italic;">Improvements to Nonemployee Share-Based Payment Accounting</div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07”</div>), which supersedes ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">505</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div> and expands the scope of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div> to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within those annual periods. Early adoption is permitted, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> earlier than a company's adoption date of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606.</div> The Company is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div><div style="display: inline; font-style: italic;">) </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10”</div>), which amends certain aspects of the Board’s new revenue standard, ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> which is effective for annual and interim periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Early adoption is permitted. We have selected the modified retrospective approach as our transition method under ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> and the financial impact to the financial statements was to decrease retained earnings and deferred revenue by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.9</div> million effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 (</div>Please see footnote <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>).</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases (Topic </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div><div style="display: inline; font-style: italic;">)</div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02”</div>)<div style="display: inline; font-style: italic;">. </div>Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the lease commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within those fiscal years (i.e., <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019, </div>for a calendar year entity). Early application is permitted.  Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> apply a full retrospective transition approach. We are currently evaluating the expected impact that the standard could have on our condensed consolidated financial statements and related disclosures.  We plan on having this analysis completed during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> <div style="display: inline; font-style: italic;">Financial Instruments - Credit Losses </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13”</div>). The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2021.</div> Early adoption is permitted. We are currently evaluating the impact of the adoption of this standard on our condensed consolidated financial statements and related disclosures.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> <div style="display: inline; font-style: italic;">Earnings Per Share (Topic </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div><div style="display: inline; font-style: italic;">); Distinguishing Liabilities from Equity (Topic </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480</div><div style="display: inline; font-style: italic;">); Derivatives and Hedging (Topic </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">815</div><div style="display: inline; font-style: italic;">): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11”</div>). The amendments in this update are intended to simplify the accounting for certain equity linked<div style="display: inline; font-style: italic;"> </div>financial instruments and embedded features with down round features that result in the strike price being reduced on the basis of the pricing of future<div style="display: inline; font-style: italic;"> </div>equity offerings. Under the new guidance, a down round feature will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer need to be considered when determining whether certain financial instruments<div style="display: inline; font-style: italic;"> </div>or embedded features should be classified as liabilities or equity instruments. That is, a down round feature will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer preclude equity classification when<div style="display: inline; font-style: italic;"> </div>assessing whether an instrument or embedded feature is indexed to an entity's own stock. In addition, the amendments clarify existing disclosure<div style="display: inline; font-style: italic;"> </div>requirements for equity-classified instruments. These amendments are effective for fiscal years, and interim periods within those years, beginning after<div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>with early adoption permitted. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> should <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on our condensed consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </div></div>

24000

14493

28985

24000

3125000

303750

112000

-4629000

898000

2000

294220000

-293324000

2000

295234000

-299865000

2000

294220000

-291447000

2775000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.</div> Subsequent Events</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 36pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2018, </div>at our Annual Stockholders Meeting, Stockholders approved an amendment to the Company's <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Stock Incentive Plan, among other things, to provide for an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,400,000</div> shares to be issued in connection with awards granted thereunder.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div></div>

10728000

132000

102.9

2.52

1.79

15913000

14299000

15906000

11578000

15913000

13885000

15906000

11578000

xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares utr:Y 0001136174 2017-01-01 2017-06-30 0001136174 cats:WarrantsRelatedToInvestorRelationsServicesMember 2017-01-01 2017-06-30 0001136174 cats:SeveralInvestorsIncludingAcuitasAndShamusMember cats:ConvertibleDebenturesMember 2017-01-01 2017-06-30 0001136174 cats:WarrantsIssuedForServicesMember 2017-01-01 2017-06-30 0001136174 cats:The2017StockIncentivePlanMember 2017-01-01 2017-06-30 0001136174 cats:The2017StockIncentivePlanMember cats:NonemployeesMember 2017-01-01 2017-06-30 0001136174 cats:SeveralInvestorsIncludingAcuitasAndShamusMember cats:ConvertibleDebenturesMember 2017-04-01 2017-04-30 0001136174 cats:ReverseStockSplitMember 2017-04-01 2017-04-30 0001136174 cats:ChairmanAndChiefExecutiveOfficerMember 2017-04-01 2017-04-30 0001136174 2017-04-01 2017-06-30 0001136174 cats:WarrantsRelatedToInvestorRelationsServicesMember 2017-04-01 2017-06-30 0001136174 cats:The2017StockIncentivePlanMember 2017-04-01 2017-06-30 0001136174 cats:The2017StockIncentivePlanMember cats:NonemployeesMember 2017-04-01 2017-06-30 0001136174 cats:JosephGunnarAndCoLLCMember cats:PublicOfferingMember 2017-04-28 2017-04-28 0001136174 cats:JosephGunnarAndCoLLCMember us-gaap:OverAllotmentOptionMember 2017-05-01 2017-05-31 0001136174 2018-01-01 2018-06-30 0001136174 cats:WarrantsRelatedToInvestorRelationsServicesMember 2018-01-01 2018-06-30 0001136174 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001136174 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cats:CustomerOneMember 2018-01-01 2018-06-30 0001136174 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cats:CustomerThreeMember 2018-01-01 2018-06-30 0001136174 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cats:CustomerTwoMember 2018-01-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerFiveMember 2018-01-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerFourMember 2018-01-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerOneMember 2018-01-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerThreeMember 2018-01-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerTwoMember 2018-01-01 2018-06-30 0001136174 cats:ARFacilityMember cats:CorporateFinanceMember 2018-01-01 2018-06-30 0001136174 cats:ARFacilityMember cats:CorporateFinanceMember us-gaap:PrimeRateMember 2018-01-01 2018-06-30 0001136174 cats:LoanAgreementMember 2018-01-01 2018-06-30 0001136174 cats:LoanAgreementMember srt:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001136174 us-gaap:FairValueInputsLevel3Member cats:WarrantsMember 2018-01-01 2018-06-30 0001136174 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-06-30 0001136174 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-06-30 0001136174 cats:WarrantsIssuedForServicesMember 2018-01-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember 2018-01-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember srt:MaximumMember 2018-01-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember srt:MinimumMember 2018-01-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember cats:NonemployeesMember 2018-01-01 2018-06-30 0001136174 cats:CommercialMember 2018-01-01 2018-06-30 0001136174 us-gaap:GovernmentContractMember 2018-01-01 2018-06-30 0001136174 cats:FurnitureAndEquipmentMember srt:MaximumMember 2018-01-01 2018-06-30 0001136174 cats:FurnitureAndEquipmentMember srt:MinimumMember 2018-01-01 2018-06-30 0001136174 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2018-01-01 2018-06-30 0001136174 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2018-01-01 2018-06-30 0001136174 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001136174 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001136174 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001136174 cats:EmployeesAndDirectorsMember 2018-01-01 2018-06-30 0001136174 2018-04-01 2018-06-30 0001136174 cats:WarrantsRelatedToInvestorRelationsServicesMember 2018-04-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerOneMember 2018-04-01 2018-06-30 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:CustomerTwoMember 2018-04-01 2018-06-30 0001136174 cats:ARFacilityMember cats:CorporateFinanceMember 2018-04-01 2018-06-30 0001136174 cats:LoanAgreementMember 2018-04-01 2018-06-30 0001136174 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-04-01 2018-06-30 0001136174 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-04-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember 2018-04-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember cats:NonemployeesMember 2018-04-01 2018-06-30 0001136174 cats:CommercialMember 2018-04-01 2018-06-30 0001136174 us-gaap:GovernmentContractMember 2018-04-01 2018-06-30 0001136174 cats:WarrantsIssuedInConnectionWithArFacilityMember 2018-06-01 2018-06-30 0001136174 cats:LoanAgreementMember 2018-06-01 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember us-gaap:SubsequentEventMember 2018-08-01 2018-08-13 0001136174 2016-12-31 0001136174 cats:JosephGunnarAndCoLLCMember us-gaap:OverAllotmentOptionMember 2017-04-28 0001136174 cats:JosephGunnarAndCoLLCMember cats:PublicOfferingMember 2017-04-28 0001136174 2017-06-30 0001136174 2017-12-31 0001136174 us-gaap:FairValueInputsLevel3Member cats:WarrantsMember 2017-12-31 0001136174 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001136174 us-gaap:CommonStockMember 2017-12-31 0001136174 us-gaap:RetainedEarningsMember 2017-12-31 0001136174 cats:EmployeesAndDirectorsMember 2017-12-31 0001136174 2018-01-01 0001136174 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001136174 2018-06-30 0001136174 cats:HeritageWarrantsMember 2018-06-30 0001136174 cats:WarrantsNotSubjectToAmendmentMember 2018-06-30 0001136174 cats:ARFacilityMember cats:CorporateFinanceMember 2018-06-30 0001136174 cats:LoanAgreementMember 2018-06-30 0001136174 cats:LoanAgreementMember srt:MaximumMember 2018-06-30 0001136174 us-gaap:CertificatesOfDepositMember 2018-06-30 0001136174 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2018-06-30 0001136174 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel2Member 2018-06-30 0001136174 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel3Member 2018-06-30 0001136174 us-gaap:FairValueInputsLevel1Member 2018-06-30 0001136174 us-gaap:FairValueInputsLevel2Member 2018-06-30 0001136174 us-gaap:FairValueInputsLevel3Member 2018-06-30 0001136174 us-gaap:FairValueInputsLevel3Member cats:WarrantsMember 2018-06-30 0001136174 us-gaap:MeasurementInputExpectedDividendRateMember 2018-06-30 0001136174 us-gaap:MeasurementInputExpectedTermMember 2018-06-30 0001136174 us-gaap:MeasurementInputPriceVolatilityMember 2018-06-30 0001136174 us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-06-30 0001136174 cats:TIHMember us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2018-06-30 0001136174 cats:The2010StockIncentivePlanMember 2018-06-30 0001136174 cats:The2017StockIncentivePlanMember 2018-06-30 0001136174 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001136174 us-gaap:CommonStockMember 2018-06-30 0001136174 us-gaap:RetainedEarningsMember 2018-06-30 0001136174 cats:EmployeesAndDirectorsMember 2018-06-30 0001136174 2018-08-13

EX-101.SCH 7 cats-20180630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Stockholders' (Deficit)/Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Consolidation and Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Document - Note 3 - ASC 606 link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Long-term Debt link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 3 - ASC 606 (Tables) link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 1 - Basis of Consolidation and Presentation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Employee and Director Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Summary of Amounts and Classification of Assets and Liabilities of the VIE in Our Consolidated Balance Sheets (Details) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 3 - ASC 606 - Adoption of ASC 606 (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 4 - Long-term Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 5 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 cats-20180630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 cats-20180630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 cats-20180630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Fair Value of Financial Instruments, Policy [Policy Text Block] Note To Financial Statement Details Textual Significant Accounting Policies Note 2 - Summary of Significant Accounting Policies Note 3 - ASC 606 Note 2 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Note 2 - Summary of Significant Accounting Policies - Calculation of Basic and Diluted Earnings Per Share (Details) Note 2 - Summary of Significant Accounting Policies - Employee and Director Stock Option Activity (Details) Long-term liabilities Note 2 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) Issuance of stock and warrants Note 2 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) Note 2 - Summary of Significant Accounting Policies - Summary of Amounts and Classification of Assets and Liabilities of the VIE in Our Consolidated Balance Sheets (Details) Fair value adjustment on warrant liability Fair Value Adjustment of Warrants Change in fair value of warrant liability Note 2 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details) Note 3 - ASC 606 - Adoption of ASC 606 (Details) Notes To Financial Statements Share-based compensation expense us-gaap_ShareBasedCompensation Share-based Compensation, Total Deposits and other assets Notes To Financial Statements [Abstract] us-gaap_DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued us-gaap_LiabilitiesCurrent Total current liabilities Title of Individual [Axis] Relationship to Entity [Domain] Earnings Per Share, Policy [Policy Text Block] Amortization of debt discount included in interest expense cats_ClassOfWarrantOrRightIssuedDuringPeriod Class of Warrant or Right, Issued During Period The number of warrants or rights issued during period. Operating expenses us-gaap_AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) Income Tax, Policy [Policy Text Block] Total assets Share-based Compensation, Stock Options, Activity [Table Text Block] us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio Depreciation and amortization us-gaap_DepreciationDepletionAndAmortization us-gaap_LiabilitiesFairValueDisclosure Total liabilities Government Contract [Member] us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share us-gaap_AssetsCurrent Total current assets Long-term assets Certificates of deposit Change in fair value of derivative liability Fair value adjustment on derivative liability Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,913,171 and 15,889,171 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively Adjustments to reconcile net loss to net cash used in operating activities: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Balance, weighted average exercise price (in dollars per share) Balance, weighted average exercise price (in dollars per share) Common stock, shares authorized (in shares) Cancelled, weighted average exercise price (in dollars per share) Common stock, shares issued (in shares) Deferred revenue Contract with Customer, Liability, Current Deferred revenue Certificates of Deposit [Member] Common stock, par value (in dollars per share) Stockholders' Equity, Policy [Policy Text Block] Granted, weighted average exercise price (in dollars per share) Accrued liabilities Accrued compensation and benefits cats_DeferredSalarySettledByShares Deferred Salary Settled by Shares The amount deferred salary balance that was settled by shares. Range [Domain] Maximum [Member] Supplemental disclosure of non-cash activity Minimum [Member] Accounts payable Ownership [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance Balance, shares (in shares) Balance, shares (in shares) Product and Service [Axis] Product and Service [Domain] Range [Axis] Credit Facility [Axis] Credit Facility [Domain] Ownership [Axis] Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding Other accrued liabilities Preferred stock, shares issued (in shares) us-gaap_PolicyTextBlockAbstract Accounting Policies Preferred stock, shares authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Preferred stock, par value (in dollars per share) Shares issuable for stock options and warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Healthcare services revenues Revenues Fair Value, Inputs, Level 3 [Member] us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Fair Value Hierarchy and NAV [Domain] Customer [Axis] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Customer [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Income taxes Warrants [Member] Represents warrants. Fair Value Hierarchy and NAV [Axis] Current liabilities us-gaap_Assets Total Assets Supplemental disclosure of cash paid Receivables, net of allowance for doubtful accounts of $0 and $476, respectively Plan Name [Axis] us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life Deferred revenue us-gaap_IncreaseDecreaseInDeferredRevenue Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total Operating activities: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Furniture and Equipment [Member] Represents furniture and equipment. Revenue Recognition, Policy [Policy Text Block] Statement [Line Items] Receivables, allowance for doubtful accounts Additional paid-in-capital Revenues: Stockholders' (deficit)/equity Leasehold Improvements [Member] Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Other income Current assets Net loss Net loss Net Income/(Loss) ASSETS Over-Allotment Option [Member] Total liabilities Total Liabilities us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities Sale of Stock [Axis] Sale of Stock [Domain] us-gaap_OperatingIncomeLoss Loss from operations Net cash used in operating activities Prepaids and other current assets us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase in cash and cash equivalents Cost of healthcare services Counterparty Name [Axis] Counterparty Name [Domain] Accounting Standards Update 2014-09 [Member] Derivatives, Policy [Policy Text Block] Warrants Issued for Services [Member] Represents warrants issued for services. Warrants Not Subject to Amendment [Member] Information regarding the warrants not subject to certain amendments. cats_SharesIssuedPricePerShareNet Shares Issued, Price Per Share, Net The per share value of shares issued, net of underwriter costs, discounts, and commissions. Property and equipment, accumulated dereciation Convertible Debentures [Member] Represents the convertible debentures. Property and equipment, net of accumulated depreciation of $1,688 and $1,542, respectively Joseph Gunnar & Co., LLC [Member] Represents the underwriter Joseph Gunnar & Co., LLC. cats_AdditionalSharesAvailableForPurchase Additional Shares Available for Purchase The maximum number of additional shares available for purchase under certain underwriting agreements. Public Offering [Member] Related to the public offering. us-gaap_PaymentOfFinancingAndStockIssuanceCosts Transaction costs Type of Adoption [Domain] Calculated under Revenue Guidance in Effect before Topic 606 [Member] Adjustments for New Accounting Pronouncements [Axis] The 2010 Stock Incentive Plan [Member] Information related to the 2010 stock incentive plan. Investing activities: Cost of Sales, Policy [Policy Text Block] Retained Earnings [Member] Proceeds of issuance of common stock Proceeds from Issuance of Common Stock Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Accounts payable and other accrued liabilities us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities us-gaap_DeferredFinanceCostsGross Debt Issuance Costs, Gross Additional Paid-in Capital [Member] Common Stock [Member] Provision for income taxes Income Tax Expense (Benefit), Total Consolidation, Variable Interest Entity, Policy [Policy Text Block] Equity Components [Axis] Equity Component [Domain] Customer Two [Member] Information pertaining to the second customer. Variable Interest Entities [Axis] Customer One [Member] Information pertaining to the first customer. Variable Interest Entity, Classification [Domain] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member] Customer Five [Member] Information pertaining to the fifth customer. Customer Four [Member] Information pertaining to the fourth customer. Schedule of Variable Interest Entities [Table Text Block] Customer Three [Member] Information pertaining to the third customer. us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income/(Loss) from operations before provision for income taxes Warrants Related to Investor Relations Services [Member] Information pertaining to warrants related to investor relations services. us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights us-gaap_OperatingExpenses Total operating expenses us-gaap_DebtInstrumentTerm Debt Instrument, Term General and administrative us-gaap_PaymentsOfDebtIssuanceCosts Debt issuance costs Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Disaggregation of Revenue [Table Text Block] Deferred rent us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Capital lease obligations Change in fair value Revenue from Contract with Customer [Text Block] us-gaap_RepaymentsOfConvertibleDebt Payment of convertible debentures EX-101.PRE 11 cats-20180630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2018	Aug. 13, 2018
Document Information [Line Items]
Entity Registrant Name	CATASYS, INC.
Entity Central Index Key	0001136174
Trading Symbol	cats
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		15,913,171
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 5,603	$ 4,779
Receivables, net of allowance for doubtful accounts of $0 and $476, respectively	1,140	511
Prepaids and other current assets	201	366
Total current assets	6,944	5,656
Long-term assets
Property and equipment, net of accumulated depreciation of $1,688 and $1,542, respectively	374	612
Deposits and other assets	578	336
Total Assets	7,896	6,604
Current liabilities
Accounts payable	1,215	980
Accrued compensation and benefits	1,403	1,177
Deferred revenue	3,416	2,914
Other accrued liabilities	1,567	578
Total current liabilities	7,601	5,649
Long-term liabilities
Long term debt, net of discount of $434 and $0, respectively	4,865
Deferred rent and other long-term liabilities		25
Capital leases		2
Warrant liabilities	59	30
Total Liabilities	12,525	5,706
Stockholders' (deficit)/equity
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,913,171 and 15,889,171 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively	2	2
Additional paid-in-capital	295,234	294,220
Accumulated deficit	(299,865)	(293,324)
Total Stockholders' (Deficit)/Equity	(4,629)	898
Total Liabilities and Stockholders' (Deficit)/Equity	$ 7,896	$ 6,604

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Receivables, allowance for doubtful accounts	$ 0	$ 476
Property and equipment, accumulated dereciation	1,688	1,542
Long term debt, discount	$ 434	$ 0
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	15,913,171	15,889,171
Common stock, shares outstanding (in shares)	15,913,171	15,889,171

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues:
Healthcare services revenues	$ 3,273,000	$ 1,665,000	$ 5,184,000	$ 3,487,000
Operating expenses
Cost of healthcare services	2,941,000	1,332,000	5,228,000	2,697,000
General and administrative	4,392,000	2,940,000	8,178,000	5,569,000
Depreciation and amortization	85,000	45,000	170,000	84,000
Total operating expenses	7,418,000	4,317,000	13,576,000	8,350,000
Loss from operations	(4,145,000)	(2,652,000)	(8,392,000)	(4,863,000)
Other income		14,000	40,000	28,000
Interest expense	(36,000)	(539,000)	(37,000)	(3,406,000)
Loss on conversion of note		(430,000)		(1,356,000)
Loss on issuance of common stock		(145,000)		(145,000)
Change in fair value of warrant liability	(19,000)	6,950,000	(29,000)	1,769,000
Change in fair value of derivative liability		10,728,000		132,000
Income/(Loss) from operations before provision for income taxes	(4,200,000)	13,926,000	(8,418,000)	(7,841,000)
Provision for income taxes		1,000	0	2,000
Net Income/(Loss)	$ (4,200,000)	$ 13,925,000	$ (8,418,000)	$ (7,843,000)
Basic net income (loss) from operations per share: (in dollars per share)	$ (0.26)	$ 1	$ (0.53)	$ (0.68)
Basic weighted number of shares outstanding (in shares)	15,913	13,885	15,906	11,578
Diluted net income (loss) from operations per share: (in dollars per share)	$ (0.26)	$ 0.97	$ (0.53)	$ (0.68)
Diluted weighted number of shares outstanding (in shares)	15,913	14,299	15,906	11,578

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating activities:
Net loss	$ (8,418,000)	$ (7,843,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	170,000	84,000
Amortization of debt discount included in interest expense	10,000	3,335,000
Issuance of stock and warrants	112,000	181,000
Loss on disposal of fixed asset	68,000
Provision for doubtful accounts		234,000
Deferred rent	(45,000)	(39,000)
Share-based compensation expense	753,000	159,000
Fair value adjustment on derivative liability		(132,000)
Fair value adjustment on warrant liability	29,000	(1,769,000)
Loss on conversion of note		1,356,000
Loss on issuance of common stock		145,000
Changes in current assets and liabilities:
Receivables	(629,000)	(169,000)
Prepaids and other current assets	165,000	242,000
Deferred revenue	2,379,000	843,000
Accounts payable and other accrued liabilities	1,486,000	164,000
Net cash used in operating activities	(3,834,000)	(3,209,000)
Investing activities:
Purchases of property and equipment		(127,000)
Net cash used in investing activities		(127,000)
Financing activities:
Proceeds of issuance of common stock		16,458,000
Proceeds from bridge loan		1,300,000
Payment of convertible debentures		(4,363,000)
Transaction costs		(1,667,000)
Proceeds from secured promissory note	5,000,000
Debt issuance costs	(324,000)
Capital lease obligations	(18,000)	(21,000)
Net cash provided by financing activities	4,658,000	11,707,000
Net increase in cash and cash equivalents	824,000	8,371,000
Cash and cash equivalents at beginning of period	4,779,000	851,000
Cash and cash equivalents at end of period	5,603,000	9,222,000
Supplemental disclosure of cash paid
Income taxes		40,000
Supplemental disclosure of non-cash activity
Common stock issued for conversion of debt and accrued interest		7,163,000
Common stock issued upon settlement of deferred compensation to officer		1,122,000
Warrants issued in connection with A/R Facility	63,000
Warrants Issued for Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants	$ 86,000

XML 17 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Stockholders' (Deficit)/Equity (Unaudited) - 6 months ended Jun. 30, 2018 - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2017	15,889,171			15,889,171
Balance at Dec. 31, 2017	$ 2	$ 294,220	$ (293,324)	$ 898
Adoption of accounting standard at Dec. 31, 2017			1,877	1,877
Balance at Dec. 31, 2017	$ 2	294,220	(291,447)	$ 2,775
Common stock issued for outside services (in shares)	24,000			24,000
Common stock issued for outside services		112		$ 112
Warrants issued for services		86		86
Warrants issued in connection with A/R facility		63		63
Share-based compensation expense		753		753
Net loss			(8,418)	$ (8,418)
Balance (in shares) at Jun. 30, 2018	15,913,171			15,913,171
Balance at Jun. 30, 2018	$ 2	$ 295,234	$ (299,865)	$ (4,629)

XML 18 R7.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Consolidation and Presentation	6 Months Ended
Note 1 - Basis of Consolidation and Presentation	Jun. 30, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1. Basis of Consolidation and Presentation We harness proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives The accompanying unaudited condensed consolidated financial statements for Catasys, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and instructions to Form 10 -Q and, therefore, do not include all disclosures necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. GAAP. In our opinion, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the entire fiscal year. The accompanying financial information should be read in conjunction with the financial statements and the notes thereto included in our most recent Annual Report on Form 10 -K for the year-ended December 31, 2017, from which the balance sheet, as of December 31, 2017, have been derived. Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our On Trak solutions in twenty states. We provide services to commercial (employer funded), managed Medicare Advantage, and managed Medicaid and duel eligible (Medicare and Medicaid) populations. We have generated fees from our launched programs and expect to increase enrollment and fees throughout 2018. Management’s Plans In June 2018 we entered into a venture loan and security agreement (the “Loan Agreement”) with Horizon Technology Finance Corporation (the “Lender”), which provides for up to $7.5 million in loans to the Company, including initial loans in the amount of $5.0 million funded upon signing of the Loan Agreement. An additional $2.5 million loan is subject to the Company’s achievement of billings of not less than $5.0 million during any three consecutive month period on or prior to November 30, 2018. Also, in June 2018, we entered into a loan and security agreement in connection with a $2.5 million receivables financing facility with Corporate Finance, a division of Heritage Bank of Commerce (the “A/R Facility”). The A/R Facility provides for the borrower entities to borrow up to 85% of the Company’s eligible accounts receivable, as defined in the A/R Facility. Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not reflect any adjustments that might result if we were unable to continue as a going concern. We entered into contracts for additional revenue-generating health plan customers and expanding our On Trak program within existing health plan customers. To support this increased demand for services, we invested in the additional headcount needed to support these customers launching during the first half of 2018. We have had a growing customer base and are able to fully scale our operations to service the contracts and future enrollment providing leverage in these investments that is expected to result in positive cash flow during the second quarter of 2019. Based upon this expected positive cash flow, we believe we will have enough capital to cover expenses through at least the next twelve months. We will continue to monitor liquidity carefully and in the event we do not have enough capital to cover expense we will make the necessary and appropriate reductions in spending to remain cash flow positive. However, if we were to add more health plans than budgeted, increase the size of the outreach pool by more than we anticipate, decide to invest in new products or seek out additional growth opportunities, we would look to finance these options via a debt financing rather than an equity financing, subject to complying with certain restrictions on the incurrence of indebtedness in our current lending facilities. All inter-company transactions have been eliminated in consolidation.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2018

Notes to Financial Statements

Significant Accounting Policies [Text Block]

Note

Summary of Significant Accounting Policies

Revenue Recognition

may

be satisfied over time or at a point in time. Revenue from a performance obligation satisfied over time is recognized by measuring our progress in satisfying the performance obligation in a manner that depicts the transfer of the goods or services to the customer. Revenue from a performance obligation satisfied at a point in time is recognized at the point in time that we determine the customer obtains control over the promised good or service. The amount of revenue recognized reflects the consideration we expect to be entitled to in exchange for those promised goods or services (

i.e.

, the “transaction price”). In determining the transaction price, we consider multiple factors, including the effects of variable consideration. Variable consideration is included in the transaction price only to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will

not

occur when the uncertainties with respect to the amount are resolved. In determining when to include variable consideration in the transaction price, we consider the range of possible outcomes, the predictive value of our past experiences, the time period of when uncertainties expect to be resolved and the amount of consideration that is susceptible to factors outside of our influence, such as the judgment and actions of

third

parties.

The following table disaggregates our revenue by contract (in thousands):

	Three Months Ended June 30, 2018					Six Months Ended June 30, 2018
	Revenue		Percentage			Revenue		Percentage

Commercial	$	2,145		66	%	$	3,245		63	%
Government		1,128		34	%		1,939		37	%
	$	3,273		100	%	$	5,184		100	%

Because the Company’s contracts have an expected duration of

one

year or less, the Company has elected the practical expedient in Accounting Standards Codification (“ASC”)

606

(a) to

not

disclose information about its remaining performance obligations.

Trak

service is provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing a continuous service to the customer. Contracts with minimum performance guarantees or price concessions include variable consideration and are subject to the revenue constraint. The Company uses an expected value method to estimate variable consideration for minimum performance guarantees and price concessions. The Company has constrained revenue for expected price concessions during the period ending

June 30, 2018.

Cost of Services

third

party administrators for processing these claims. Salaries and fees charged by our

third

party administrators for processing claims are expensed when incurred and healthcare provider claims payments are recognized in the period in which an eligible member receives services. We contract with doctors and licensed behavioral healthcare professionals, on a fee-for-service basis. We determine that a member has received services when we receive a claim or in the absence of a claim, by utilizing member data recorded in the On

Trak

database within the contracted timeframe, with all required billing elements correctly completed by the service provider.

Cash Equivalents and Concentration of Credit Risk

We consider all highly liquid investments with an original maturity of

three

months or less to be cash equivalents. Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents. Cash is deposited with what we believe are highly credited, quality financial institutions. The deposited cash

may

exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. As of

June 30, 2018,

we had

$5.4

million in cash and cash equivalents exceeding federally insured limits.

For the

six

months ended

June 30, 2018,

five

customers accounted for approximately

93%

of revenues (

26%,

25%,

16%,

15%,

and

11%

) and

three

customers accounted for approximately

71%

of accounts receivable (

42%,

17%,

and

12%

For the

three

months ended

June 30, 2018,

two

customers accounted for approximately

36%

of revenues (

19%

and

17%

Basic and Diluted

Income (

Loss

)

per Share

Common equivalent shares, consisting of

4,571,912

and

2,255,381

common shares for the

six

months ended

June 30, 2018

and

2017,

issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.

Common equivalent shares, consisting of

413,701

incremental common shares for the

three

months ended

June 30, 2017,

issuable upon the exercise of warrants have been included in the diluted earnings per share calculation.

	Three Months Ended					Six Months Ended
	June 30					June 30
(in thousands, except per share amounts)	2018			2017		2018			2017

Numerator

Net income (loss)	$	(4,200	)	$	13,925	$	(8,418	)	$	(7,843	)

Denominator

Weighted-average common shares outstanding		15,913			13,885		15,906			11,578

Shares used in calculation - basic		15,913			13,885		15,906			11,578

Shares issuable for stock options and warrants		-			414		-			-

Shares used in calculation - diluted		15,913			14,299		15,906			11,578

Net income (loss) per share from operations

Basic	$	(0.26	)	$	1.00	$	(0.53	)	$	(0.68	)

Diluted	$	(0.26	)	$	0.97	$	(0.53	)	$	(0.68	)

Share-Based Compensation

Our

2017

Stock Incentive Plan (the

“2017

Plan”), provides for the issuance of up to

2,333,334

shares of our common stock and an additional

243,853

shares of our common stock that are represented by awards granted under our

2010

Stock Incentive Plan (the

“2010

Plan”). Incentive stock options (ISOs) under Section

422A

of the Internal Revenue Code and non-qualified options (NSOs) are authorized under the

2017

Plan. We have granted stock options to executive officers, employees, members of our board of directors, and certain outside consultants. The terms and conditions upon which options become exercisable vary among grants, but option rights expire

later than

ten

years from the date of grant and employee and board of director awards generally vest over

three

five

years. As of

June 30, 2018,

we had

2,526,664

shares outstanding, of which

368,609

shares are vested and

50,523

shares are available for future awards under the

2017

Plan.

Share-based compensation expense attributable to operations were approximately

$425,000

and

$753,000

for the

three

and

six

months ended

June 30, 2018,

respectively compared with approximately

$32,000

and

$159,000

for the same periods in

2017,

respectively.

Stock Options – Employees and Directors

three

and

six

months ended

June 30, 2018

and

2017

is based on awards ultimately expected to vest, reduced for estimated forfeitures. Accounting rules for stock options require forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

There were

642,307

options granted to employees and directors during the

three

and

six

months ended

June 30, 2018

compared with

options granted during the same periods in

2017.

Employee and director stock option activity for the

six

months ended

June 30, 2018

are as follows:

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2017		1,885,383		$	11.46

Granted		642,307			7.50
Cancelled		(1,026	)		546.19

Balance June 30, 2018		2,526,664		$	10.24

three

and

six

months ended

June 30, 2018

and

2017,

reflects the application of the simplified method prescribed in Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”)

No.

107

(as amended by SAB

110

), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.

As of

June 30, 2018,

there was

$6.7

million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the

2017

Plan. That cost is expected to be recognized over a weighted-average period of approximately

3.5

years.

Stock Options and Warrants – Non-employees

There were

options issued to non-employees for the

three

and

six

months ended

June 30, 2018

or in the same periods in

2017.

There was

share-based compensation expense relating to stock options and warrants recognized for non-employees for the

three

and

six

months ended

June 30, 2018

or in the same periods in

2017.

There were

and

24,000

warrants issued in exchange for services during the

three

months and

six

months ended

June 30, 2018,

compared with

90,000

options issued in exchange for services during the same periods in

2017.

Generally, the costs associated with warrants issued for services are amortized to the related expense on a straight-line basis over the related service periods.

There were

9,720

warrants issued in connection with the

June 2018

A/R Facility financing (see Footnote

There were

2,045,248

and

2,011,528

warrants outstanding as of

June 30, 2018

and

2017,

respectively.

Common Stock

There were

and

24,000

shares of common stock issued in exchange for investor relations services during the

three

and

six

months ended

June 30, 2018,

respectively, compared with

14,493

and

28,985

for the same periods in

2017.

Generally, the costs associated with shares issued for services are amortized to the related expense on a straight-line basis over the related service periods.

April 2017,

we entered into an underwriting agreement with Joseph Gunnar & Co., LLC (“Joseph Gunnar”), as underwriter in connection with a public offering of the Company’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate

3,125,000

shares of common stock at a public offering price of

$4.80

per share, and the purchase price to the underwriter after discounts and commission was

$4.464

per share. The closing of the offering occurred on

April 28, 2017.

We received

$15.0

million in gross proceeds in connection with the offering.

Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a

day over-allotment option to purchase up to

468,750

additional shares of common stock at the public offering price less the applicable underwriter discount. In

May,

the underwriter acquired an additional

303,750

shares pursuant to such over-allotment option. We received

$1.5

million in gross proceeds in connection with the over-allotment option.

In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on

April 26, 2017.

April 2017,

several investors, including Acuitas Group Holdings, LLC (“Acuitas”),

one hundred

percent (

100%

) of which is owned by Terren S. Peizer, Chairman and Chief Executive Officer of the Company, and Shamus, LLC (“Shamus”), a Company owned by David E. Smith, a member of our board of directors, exercised their option to convert their convertible debentures and received

2,982,994

shares of common stock. There was a loss on the conversion of the convertible debentures of

$1.4

million for the

six

months ended

June 30, 2017.

April 2017,

Terren S. Peizer agreed to settle his deferred salary balance of

$1.1

million for

233,734

shares of common stock. As a result, the Company recognized a loss on settlement of liability totaling

$83,807

which is recorded to loss on issuance of common stock.

April 2017,

we filed a certificate of amendment to our Certificate of Incorporation, as amended and in effect, with the Secretary of State of the State of Delaware, implementing a

-for-

reverse stock split of the Company's common stock, pursuant to which each

six

shares of issued and outstanding common stock converted into

one

share of common stock. Proportionate voting rights and other rights of common stock holders were

not

affected by the reverse stock split.

fractional shares of common stock were issued as a result of the reverse stock split; stockholders were paid cash in lieu of any such fractional shares.

six

and, as applicable, multiplying the exercise price by

six

as a result of the reverse stock split.

Income Taxes

We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of

June 30, 2018.

As such, we have

not

recorded a provision for income tax for the period ended

June 30, 2018.

We utilize the liability method of accounting for income taxes as set forth in ASC

740,

Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than

not

that some of the deferred tax assets will

not

be realized.

50%

likelihood that a tax benefit will be sustained, we have recorded the largest amount of tax benefit that

may

potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than

50%

likelihood that a tax benefit will be sustained,

tax benefit has been recognized in the financial statements. Based on management's assessment of the facts, circumstances and information available, management has determined that all of the tax benefits for the period ended

June 30, 2018

should be realized.

Fair Value Measurements

) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (

) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of

three

broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The

three

levels of the fair value hierarchy are described below:

Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II		Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at

June 30, 2018

for assets and liabilities measured at fair value:

	Balance at June 30, 2018


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		71		-		-		71
Total assets		71		-		-		71

Warrant liabilities		-		-		59		59
Total liabilities		-		-		59		59

Financial instruments classified as Level III in the fair value hierarchy as of

June 30, 2018,

represent our liabilities measured at market value on a recurring basis which include warrant liabilities resulting from recent debt financings. In accordance with current accounting rules, the warrant liabilities with anti-dilution protection are being marked-to-market each quarter-end until they are completely settled or expire. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See

Warrant Liabilities

below.

The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the

six

months ended

June 30, 2018:

	Level III
	Warrant
(Dollars in thousands)	Liabilities
Balance as of December 31, 2017	$	30
Issuance of warrants		-
Change in fair value		29
Balance as of June 30, 2018	$	59

Property and Equipment

two

seven

years for furniture and equipment. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the related lease term, which is typically

five

seven

years.

Variable Interest Entities

not

absorb the expected losses or receive the expected returns of the entity. When determining whether an entity that is a business qualifies as a VIE, we also consider whether (i) we participated significantly in the design of the entity, (ii) we provided more than half of the total financial support to the entity, and (iii) substantially all of the activities of the VIE either involve us or are conducted on our behalf. A VIE is consolidated by its primary beneficiary, which is the party that absorbs or receives a majority of the entity’s expected losses or expected residual returns.

As discussed under the heading

Management Services Agreement

(“MSA”) below, we have an MSA with a Texas nonprofit health organization (“TIH”). Under this MSA, the equity owner of TIH has only a nominal equity investment at risk, and we absorb or receive a majority of the entity’s expected losses or expected residual returns. We participate significantly in the design of this MSA. We also agree to provide working capital loans to allow for TIH to pay for its obligations. Substantially all of the activities of TIH either involve us or are conducted for our benefit, as evidenced by the facts that (i) the operations of the TIH are conducted primarily using our licensed network of providers and (ii) under the MSA, we agree to provide and perform all non-medical management and administrative services for the medical group. Payment of our management fee is subordinate to payments of the obligations of TIH, and repayment of the working capital loans is

not

guaranteed by the equity owner of the affiliated medical group or other

third

party. Creditors of TIH do

not

have recourse to our general credit.

Management Services Agreement

April 2018,

we executed an MSA with TIH. Under the MSA, we license to TIH the right to use our proprietary treatment programs and related trademarks and provide all required day-to-day business management services, including, but

not

limited to:

●

general administrative support services;

●

information systems;

●

recordkeeping;

●

billing and collection;

●

obtaining and maintaining all federal, state and local licenses, certifications and regulatory permits.

five

-year period), (b)

10%

15%

of the foregoing costs, and (c) any performance bonus amount, as determined by the treatment center at its sole discretion. The treatment center’s payment of our fee is subordinate to payment of the treatment center's obligations, including physician fees and medical group employee compensation.

not

guaranteed by the equity owner of TIH or other

third

party. Creditors of TIH do

not

have recourse to our general credit. Based on these facts, we have determined that TIH is a VIE and that we are the primary beneficiary as defined in current accounting rules. Accordingly, we are required to consolidate the assets, liabilities, revenues and expenses of the managed treatment center.

The amounts and classification of assets and liabilities of the VIE included in our consolidated balance sheets at

June 30, 2018

are as follows:

(in thousands)	June 30, 201 8
Cash and cash equivalents	$	96

Accounts payable		7
Accrued liabilities		50
Total liabilities	$	57

Warrant Liabilities

The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions:

	June 30 , 201 8
Expected volatility		102.90	%
Risk-free interest rate		2.52	%
Weighted average expected lives in years		1.79
Expected dividend		0	%

We issued

11,049

warrants to purchase common stock in

April 2015

which are being accounted for as liabilities in accordance with Financial Accounting Standards Board (“FASB”) accounting rules, due to anti-dilution provisions in the warrants that protect the holders from declines in our stock price, which is considered outside our control. These warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.

For the

three

and

six

months ended

June 30, 2018,

we recognized a loss of

$19,000

and

$29,000,

respectively, compared with a gain of

$7.0

million and

$1.8

million for the same periods in

2017,

respectively, related to the revaluation of our warrant liabilities.

Recently Issued or Newly Adopted Accounting Standards

June 2018,

the FASB issued Accounting Standard Update (“ASU”)

2018

07,

Improvements to Nonemployee Share-Based Payment Accounting

(“ASU

2018

07”

), which supersedes ASC

505

and expands the scope of ASC

718

to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after

December

15,

2018,

including interim periods within those annual periods. Early adoption is permitted, but

earlier than a company's adoption date of ASC

606.

The Company is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

April 2016,

the FASB issued ASU

2016

10,

Revenue from Contracts with Customers (Topic

606

)

(“ASU

2016

10”

), which amends certain aspects of the Board’s new revenue standard, ASU

2014

09,

Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU

2014

09,

which is effective for annual and interim periods beginning after

December 15, 2017.

Early adoption is permitted. We have selected the modified retrospective approach as our transition method under ASU

2016

and the financial impact to the financial statements was to decrease retained earnings and deferred revenue by

$1.9

million effective

January 1, 2018 (

Please see footnote

February 2016,

the FASB ASU

No.

2016

02,

Leases (Topic

842

)

(“ASU

2016

02”

)

Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the lease commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic

606,

Revenue from Contracts with Customers

. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will

longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU

2016

for fiscal years beginning after

December 15, 2018,

including interim periods within those fiscal years (i.e.,

January 1, 2019,

for a calendar year entity). Early application is permitted. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would

not

require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors

may

not

apply a full retrospective transition approach. We are currently evaluating the expected impact that the standard could have on our condensed consolidated financial statements and related disclosures. We plan on having this analysis completed during the

fourth

quarter of

2018.

June 2016,

the FASB issued ASU

2016

13,

Financial Instruments - Credit Losses

(“ASU

2016

13”

). The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but

not

limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the

first

quarter of fiscal year

2021.

Early adoption is permitted. We are currently evaluating the impact of the adoption of this standard on our condensed consolidated financial statements and related disclosures.

July 2017,

the FASB issued ASU

2017

11,

Earnings Per Share (Topic

260

); Distinguishing Liabilities from Equity (Topic

480

); Derivatives and Hedging (Topic

815

): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception

(“ASU

2017

11”

). The amendments in this update are intended to simplify the accounting for certain equity linked

financial instruments and embedded features with down round features that result in the strike price being reduced on the basis of the pricing of future

equity offerings. Under the new guidance, a down round feature will

longer need to be considered when determining whether certain financial instruments

or embedded features should be classified as liabilities or equity instruments. That is, a down round feature will

longer preclude equity classification when

assessing whether an instrument or embedded feature is indexed to an entity's own stock. In addition, the amendments clarify existing disclosure

requirements for equity-classified instruments. These amendments are effective for fiscal years, and interim periods within those years, beginning after

December 15, 2018,

with early adoption permitted. The adoption of ASU

2017

should

not

have a material impact on our condensed consolidated financial statements.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Note 3 - ASC 606

6 Months Ended

Jun. 30, 2018

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

Note

ASC

606

May 2014,

the FASB issued ASU

No.

2014

09,

Revenue from Contracts with Customers (Topic

606

)

(“ASU

2014

09”

). ASU

2014

supersedes the revenue recognition requirements in ASC

605

- Revenue Recognition (“ASC

605”

) and most industry-specific guidance throughout ASC

605.

The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures. The core principle of ASC

606

requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services.

We adopted ASC

606

effective

January 1, 2018

using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The comparative information has

not

been restated and continues to be reported under the accounting standards in effect for those periods. The cumulative effect of the changes made to our consolidated

January 1, 2018

balance sheet for the adoption of ASU

2014

were as follows (in thousands):

	Balance at December 31, 2017			Adjustments Due to Adoption of ASC606		Balance at January 1, 2018
Balance Sheet
Liabilities
Deferred revenue	$	(2,914	)	$	1,877	$	(1,037	)

Equity
Retained earnings		(293,324	)		1,877		(291,447	)

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated income statement and balance sheet for the

three

and

six

months ended

June 30, 2018

was as follows (in thousands):

	Three Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	3,273		$	1,734		$	1,539

Net loss		(4,200	)		(5,739	)		1,539

	Six Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	5,184		$	2,886		$	2,298

Net loss		(8,418	)		(10,716	)		2,298

XML 21 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Long-term Debt	6 Months Ended
Note 4 - Long-term Debt	Jun. 30, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 4. Long-Term Debt In June 2018 we entered into a venture loan and security agreement (the “Loan Agreement”) with Horizon Technology Finance Corporation (the “Lender”), which provides for up to $7.5 million in loans to the Company, including initial loans in the amount of $5.0 million funded upon signing of the Loan Agreement. An additional $2.5 million loan is subject to the Company’s achievement of billings of not less than $5.0 million during any three consecutive month period on or prior to November 30, 2018. Repayment of the loans is on an interest-only basis through September 1, 2019, followed by monthly payments of principal and accrued interest for the balance of the term, subject to extension in the event the billings of the Company exceed $20.0 million during the six months period ended June 30, 2019. The loans bear interest at a floating coupon rate of 8.75% plus the amount by which one -month LIBOR exceeds 2.0%. We have also agreed to make quarterly revenue based payments to the Lender in the amount of 0.2% of their consolidated revenue in accordance with GAAP, in any quarter in which the Company’s EBITDA is negative, or 0.4% of such consolidated revenue if the Company’s EBITDA is positive. A final payment equal to 6.0% of each loan tranche will be due on the scheduled maturity date of March 1, 2022 for each loan. In addition, if we repay all or a portion of the loan prior to the applicable maturity date, we will pay the Lender a prepayment penalty fee, based on a percentage of the then outstanding principal balance, equal to 3% if the prepayment occurs during the interest-only payment period, 2% thereafter, plus the amount by which the Revenue Based Payments received prior to such prepayment did not exceed certain minimum thresholds. We paid $23,000 in interest for the three and six months ended June 30, 2018. Obligations under the Loan Agreement are secured by a first priority security interest in all of our respective assets, with the exception of intellectual property. We have agreed not to pledge or otherwise encumber our intellectual property assets, subject to certain exceptions. The Loan Agreement includes customary affirmative and restrictive covenants, excluding any covenants to attain or maintain certain financial metrics, and also includes customary events of default, including for payment failures, breaches of covenants, change of control and material adverse changes. Upon the occurrence of an event of default and following any applicable cure periods, a default interest rate of an additional 5% may be applied to the outstanding loan balances (and a late payment fee of 6% of the amount due incurred), and the Lender may declare all outstanding obligations immediately due and payable and take such other actions as set forth in the Loan Agreement. In connection with the Loan Agreement, the Company obligated to pay the Lender a $75,000 commitment fee. We recognized approximately $438,000 of debt discount associated with this Loan Agreement, which is being amortized to interest expense using the effective interest method over the term of the Loan Agreement. Amortization of the debt discount associated with the Loan Agreement was approximately $4,000 for the three and six months ended June 30, 2018 and is included in interest expense in the accompanying condensed consolidated statements of operations. Also in June 2018, we entered into a loan and security agreement in connection with a $2.5 million receivables financing facility with Corporate Finance, a division of Heritage Bank of Commerce (the “A/R Facility”). The A/R Facility provides for us to borrow up to 85% of the Company’s eligible accounts receivable, as defined in the A/R Facility. Interest on such borrowings accrues at the rate of the Wall Street Journal Prime Rate plus 3.0%. The lender under the A/R Facility is entitled to an annual facility fee of 1% and the initial term of the A/R Facility is two years. Obligations under the A/R Facility are secured by a first priority security interest in all of the personal property of the Company, with the exception of intellectual property, and are senior to all borrowings under the Loan Agreement pursuant to an intercreditor agreement. In connection with the A/R Facility agreement, we issued Heritage Bank of Commerce warrants to purchase an aggregate of 9,720 shares of common stock (the “Heritage Warrants”), subject to a reduction in the event of early termination of the AR Facility agreement. These warrants were recorded as debt issuance costs as well as all fees associated with securing the A/R Facility and are being amortized to interest expense over the two -years term of the A/R Facility using the straight-line method. We recognized approximately $248,000 of debt issuance costs associated with the A/R Facility, and the amortization of the debt issuance costs associated with the A/R Facility was approximately $6,000 for the three and six months ended June 30, 2018 and is included in interest expense in the accompanying condensed consolidated statements of operations.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Note 5 - Subsequent Events	6 Months Ended
Note 5 - Subsequent Events	Jun. 30, 2018
Notes to Financial Statements
Subsequent Events [Text Block]	Note 5. Subsequent Events In August 2018, at our Annual Stockholders Meeting, Stockholders approved an amendment to the Company's 2017 Stock Incentive Plan, among other things, to provide for an additional 1,400,000 shares to be issued in connection with awards granted thereunder.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

may

i.e.

not

third

parties.

The following table disaggregates our revenue by contract (in thousands):

	Three Months Ended June 30, 2018					Six Months Ended June 30, 2018
	Revenue		Percentage			Revenue		Percentage

Commercial	$	2,145		66	%	$	3,245		63	%
Government		1,128		34	%		1,939		37	%
	$	3,273		100	%	$	5,184		100	%

Because the Company’s contracts have an expected duration of

one

year or less, the Company has elected the practical expedient in Accounting Standards Codification (“ASC”)

606

(a) to

not

disclose information about its remaining performance obligations.

Trak

June 30, 2018.

Cost of Sales, Policy [Policy Text Block]

Cost of Services

third

party administrators for processing these claims. Salaries and fees charged by our

third

Trak

database within the contracted timeframe, with all required billing elements correctly completed by the service provider.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash Equivalents and Concentration of Credit Risk

We consider all highly liquid investments with an original maturity of

three

may

exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. As of

June 30, 2018,

we had

$5.4

million in cash and cash equivalents exceeding federally insured limits.

For the

six

months ended

June 30, 2018,

five

customers accounted for approximately

93%

of revenues (

26%,

25%,

16%,

15%,

and

11%

) and

three

customers accounted for approximately

71%

of accounts receivable (

42%,

17%,

and

12%

For the

three

months ended

June 30, 2018,

two

customers accounted for approximately

36%

of revenues (

19%

and

17%

Earnings Per Share, Policy [Policy Text Block]

Basic and Diluted

Income (

Loss

)

per Share

Common equivalent shares, consisting of

4,571,912

and

2,255,381

common shares for the

six

months ended

June 30, 2018

and

2017,

issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.

Common equivalent shares, consisting of

413,701

incremental common shares for the

three

months ended

June 30, 2017,

issuable upon the exercise of warrants have been included in the diluted earnings per share calculation.

	Three Months Ended					Six Months Ended
	June 30					June 30
(in thousands, except per share amounts)	2018			2017		2018			2017

Numerator

Net income (loss)	$	(4,200	)	$	13,925	$	(8,418	)	$	(7,843	)

Denominator

Weighted-average common shares outstanding		15,913			13,885		15,906			11,578

Shares used in calculation - basic		15,913			13,885		15,906			11,578

Shares issuable for stock options and warrants		-			414		-			-

Shares used in calculation - diluted		15,913			14,299		15,906			11,578

Net income (loss) per share from operations

Basic	$	(0.26	)	$	1.00	$	(0.53	)	$	(0.68	)

Diluted	$	(0.26	)	$	0.97	$	(0.53	)	$	(0.68	)

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Share-Based Compensation

Our

2017

Stock Incentive Plan (the

“2017

Plan”), provides for the issuance of up to

2,333,334

shares of our common stock and an additional

243,853

shares of our common stock that are represented by awards granted under our

2010

Stock Incentive Plan (the

“2010

Plan”). Incentive stock options (ISOs) under Section

422A

of the Internal Revenue Code and non-qualified options (NSOs) are authorized under the

2017

later than

ten

years from the date of grant and employee and board of director awards generally vest over

three

five

years. As of

June 30, 2018,

we had

2,526,664

shares outstanding, of which

368,609

shares are vested and

50,523

shares are available for future awards under the

2017

Plan.

Share-based compensation expense attributable to operations were approximately

$425,000

and

$753,000

for the

three

and

six

months ended

June 30, 2018,

respectively compared with approximately

$32,000

and

$159,000

for the same periods in

2017,

respectively.

Stock Options – Employees and Directors

three

and

six

months ended

June 30, 2018

and

2017

There were

642,307

options granted to employees and directors during the

three

and

six

months ended

June 30, 2018

compared with

options granted during the same periods in

2017.

Employee and director stock option activity for the

six

months ended

June 30, 2018

are as follows:

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2017		1,885,383		$	11.46

Granted		642,307		$	7.50
Cancelled		(1,026	)		546.19

Balance June 30, 2018		2,526,664		$	10.24

three

and

six

months ended

June 30, 2018

and

2017,

reflects the application of the simplified method prescribed in Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”)

No.

107

(as amended by SAB

110

), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.

As of

June 30, 2018,

there was

$6.7

million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the

2017

Plan. That cost is expected to be recognized over a weighted-average period of approximately

3.5

years.

Stock Options and Warrants – Non-employees

There were

options issued to non-employees for the

three

and

six

months ended

June 30, 2018

or in the same periods in

2017.

There was

share-based compensation expense relating to stock options and warrants recognized for non-employees for the

three

and

six

months ended

June 30, 2018

or in the same periods in

2017.

There were

and

24,000

warrants issued in exchange for services during the

three

months and

six

months ended

June 30, 2018,

compared with

90,000

options issued in exchange for services during the same periods in

2017.

Generally, the costs associated with warrants issued for services are amortized to the related expense on a straight-line basis over the related service periods.

There were

9,720

warrants issued in connection with the

June 2018

A/R Facility financing (see Footnote

There were

2,045,248

and

2,011,528

warrants outstanding as of

June 30, 2018

and

2017,

respectively.

Stockholders' Equity, Policy [Policy Text Block]

Common Stock

There were

and

24,000

shares of common stock issued in exchange for investor relations services during the

three

and

six

months ended

June 30, 2018,

respectively, compared with

14,493

and

28,985

for the same periods in

2017.

Generally, the costs associated with shares issued for services are amortized to the related expense on a straight-line basis over the related service periods.

April 2017,

3,125,000

shares of common stock at a public offering price of

$4.80

per share, and the purchase price to the underwriter after discounts and commission was

$4.464

per share. The closing of the offering occurred on

April 28, 2017.

We received

$15.0

million in gross proceeds in connection with the offering.

Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a

day over-allotment option to purchase up to

468,750

additional shares of common stock at the public offering price less the applicable underwriter discount. In

May,

the underwriter acquired an additional

303,750

shares pursuant to such over-allotment option. We received

$1.5

million in gross proceeds in connection with the over-allotment option.

In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on

April 26, 2017.

April 2017,

several investors, including Acuitas Group Holdings, LLC (“Acuitas”),

one hundred

percent (

100%

2,982,994

shares of common stock. There was a loss on the conversion of the convertible debentures of

$1.4

million for the

six

months ended

June 30, 2017.

April 2017,

Terren S. Peizer agreed to settle his deferred salary balance of

$1.1

million for

233,734

shares of common stock. As a result, the Company recognized a loss on settlement of liability totaling

$83,807

which is recorded to loss on issuance of common stock.

April 2017,

we filed a certificate of amendment to our Certificate of Incorporation, as amended and in effect, with the Secretary of State of the State of Delaware, implementing a

-for-

reverse stock split of the Company's common stock, pursuant to which each

six

shares of issued and outstanding common stock converted into

one

share of common stock. Proportionate voting rights and other rights of common stock holders were

not

affected by the reverse stock split.

fractional shares of common stock were issued as a result of the reverse stock split; stockholders were paid cash in lieu of any such fractional shares.

six

and, as applicable, multiplying the exercise price by

six

as a result of the reverse stock split.

Income Tax, Policy [Policy Text Block]

Income Taxes

We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of

June 30, 2018.

As such, we have

not

recorded a provision for income tax for the period ended

June 30, 2018.

We utilize the liability method of accounting for income taxes as set forth in ASC

740,

not

that some of the deferred tax assets will

not

be realized.

50%

likelihood that a tax benefit will be sustained, we have recorded the largest amount of tax benefit that

may

potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than

50%

likelihood that a tax benefit will be sustained,

June 30, 2018

should be realized.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value Measurements

) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (

) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of

three

levels of the fair value hierarchy are described below:

Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II		Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at

June 30, 2018

for assets and liabilities measured at fair value:

	Balance at June 30, 2018


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		71		-		-		71
Total assets		71		-		-		71

Warrant liabilities		-		-		59		59
Total liabilities		-		-		59		59

Financial instruments classified as Level III in the fair value hierarchy as of

June 30, 2018,

Warrant Liabilities

below.

The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the

six

months ended

June 30, 2018:

	Level III
	Warrant
(Dollars in thousands)	Liabilities
Balance as of December 31, 2017	$	30
Issuance of warrants		-
Change in fair value		29
Balance as of June 30, 2018	$	59

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

two

seven

years for furniture and equipment. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the related lease term, which is typically

five

seven

years.

Consolidation, Variable Interest Entity, Policy [Policy Text Block]

Variable Interest Entities

not

As discussed under the heading

Management Services Agreement

not

guaranteed by the equity owner of the affiliated medical group or other

third

party. Creditors of TIH do

not

have recourse to our general credit.

Management Services Agreement

April 2018,

not

limited to:

●

general administrative support services;

●

information systems;

●

recordkeeping;

●

billing and collection;

●

obtaining and maintaining all federal, state and local licenses, certifications and regulatory permits.

five

-year period), (b)

10%

15%

not

guaranteed by the equity owner of TIH or other

third

party. Creditors of TIH do

not

The amounts and classification of assets and liabilities of the VIE included in our consolidated balance sheets at

June 30, 2018

are as follows:

(in thousands)	June 30, 201 8
Cash and cash equivalents	$	96

Accounts payable		7
Accrued liabilities		50
Total liabilities	$	57

Derivatives, Policy [Policy Text Block]

Warrant Liabilities

The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions:

	June 30 , 201 8
Expected volatility		102.90	%
Risk-free interest rate		2.52	%
Weighted average expected lives in years		1.79
Expected dividend		0	%

We issued

11,049

warrants to purchase common stock in

April 2015

For the

three

and

six

months ended

June 30, 2018,

we recognized a loss of

$19,000

and

$29,000,

respectively, compared with a gain of

$7.0

million and

$1.8

million for the same periods in

2017,

respectively, related to the revaluation of our warrant liabilities.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued or Newly Adopted Accounting Standards

June 2018,

the FASB issued Accounting Standard Update (“ASU”)

2018

07,

Improvements to Nonemployee Share-Based Payment Accounting

(“ASU

2018

07”

), which supersedes ASC

505

and expands the scope of ASC

718

December

15,

2018,

including interim periods within those annual periods. Early adoption is permitted, but

earlier than a company's adoption date of ASC

606.

The Company is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

April 2016,

the FASB issued ASU

2016

10,

Revenue from Contracts with Customers (Topic

606

)

(“ASU

2016

10”

), which amends certain aspects of the Board’s new revenue standard, ASU

2014

09,

Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU

2014

09,

which is effective for annual and interim periods beginning after

December 15, 2017.

Early adoption is permitted. We have selected the modified retrospective approach as our transition method under ASU

2016

and the financial impact to the financial statements was to decrease retained earnings and deferred revenue by

$1.9

million effective

January 1, 2018 (

Please see footnote

February 2016,

the FASB ASU

No.

2016

02,

Leases (Topic

842

)

(“ASU

2016

02”

)

606,

Revenue from Contracts with Customers

. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will

longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU

2016

for fiscal years beginning after

December 15, 2018,

including interim periods within those fiscal years (i.e.,

January 1, 2019,

not

require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors

may

not

fourth

quarter of

2018.

June 2016,

the FASB issued ASU

2016

13,

Financial Instruments - Credit Losses

(“ASU

2016

13”

not

limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the

first

quarter of fiscal year

2021.

Early adoption is permitted. We are currently evaluating the impact of the adoption of this standard on our condensed consolidated financial statements and related disclosures.

July 2017,

the FASB issued ASU

2017

11,

Earnings Per Share (Topic

260

); Distinguishing Liabilities from Equity (Topic

480

); Derivatives and Hedging (Topic

815

(“ASU

2017

11”

). The amendments in this update are intended to simplify the accounting for certain equity linked

financial instruments and embedded features with down round features that result in the strike price being reduced on the basis of the pricing of future

equity offerings. Under the new guidance, a down round feature will

longer need to be considered when determining whether certain financial instruments

or embedded features should be classified as liabilities or equity instruments. That is, a down round feature will

longer preclude equity classification when

assessing whether an instrument or embedded feature is indexed to an entity's own stock. In addition, the amendments clarify existing disclosure

requirements for equity-classified instruments. These amendments are effective for fiscal years, and interim periods within those years, beginning after

December 15, 2018,

with early adoption permitted. The adoption of ASU

2017

should

not

have a material impact on our condensed consolidated financial statements.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2018

Notes Tables

Disaggregation of Revenue [Table Text Block]

	Three Months Ended June 30, 2018					Six Months Ended June 30, 2018
	Revenue		Percentage			Revenue		Percentage

Commercial	$	2,145		66	%	$	3,245		63	%
Government		1,128		34	%		1,939		37	%
	$	3,273		100	%	$	5,184		100	%

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended					Six Months Ended
	June 30					June 30
(in thousands, except per share amounts)	2018			2017		2018			2017

Numerator

Net income (loss)	$	(4,200	)	$	13,925	$	(8,418	)	$	(7,843	)

Denominator

Weighted-average common shares outstanding		15,913			13,885		15,906			11,578

Shares used in calculation - basic		15,913			13,885		15,906			11,578

Shares issuable for stock options and warrants		-			414		-			-

Shares used in calculation - diluted		15,913			14,299		15,906			11,578

Net income (loss) per share from operations

Basic	$	(0.26	)	$	1.00	$	(0.53	)	$	(0.68	)

Diluted	$	(0.26	)	$	0.97	$	(0.53	)	$	(0.68	)

Share-based Compensation, Stock Options, Activity [Table Text Block]

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2017		1,885,383		$	11.46

Granted		642,307			7.50
Cancelled		(1,026	)		546.19

Balance June 30, 2018		2,526,664		$	10.24

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Balance at June 30, 2018


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		71		-		-		71
Total assets		71		-		-		71

Warrant liabilities		-		-		59		59
Total liabilities		-		-		59		59

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

	Level III
	Warrant
(Dollars in thousands)	Liabilities
Balance as of December 31, 2017	$	30
Issuance of warrants		-
Change in fair value		29
Balance as of June 30, 2018	$	59

Schedule of Variable Interest Entities [Table Text Block]

(in thousands)	June 30, 201 8
Cash and cash equivalents	$	96

Accounts payable		7
Accrued liabilities		50
Total liabilities	$	57

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

	June 30 , 201 8
Expected volatility		102.90	%
Risk-free interest rate		2.52	%
Weighted average expected lives in years		1.79
Expected dividend		0	%

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

Note 3 - ASC 606 (Tables)

6 Months Ended

Jun. 30, 2018

Notes Tables

Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]

	Balance at December 31, 2017			Adjustments Due to Adoption of ASC606		Balance at January 1, 2018
Balance Sheet
Liabilities
Deferred revenue	$	(2,914	)	$	1,877	$	(1,037	)

Equity
Retained earnings		(293,324	)		1,877		(291,447	)

	Three Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	3,273		$	1,734		$	1,539

Net loss		(4,200	)		(5,739	)		1,539

	Six Months Ended June 30, 2018
	As Reported			Balances Without Adoption of ASC 606			Effect of Change Higher/(Lower)
Income Statement
Revenues
Healthcare services revenues	$	5,184		$	2,886		$	2,298

Net loss		(8,418	)		(10,716	)		2,298

XML 26 R15.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Consolidation and Presentation (Details Textual)	1 Months Ended	6 Months Ended
	Jun. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)
Corporate Finance [Member] \| A/R Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,500,000	$ 2,500,000
Line of Credit Facility, Percentage of Accounts Receivable as Borrowings	85.00%	85.00%
Loan Agreement [Member]
Debt Instrument, Face Amount	$ 5	$ 5
Debt Instrument, Face Amount of Potential Additional Loan	2.50	2.50
Debt Instrument, Billings Threshold for Additional Loan	5,000,000	5,000,000
Maximum [Member] \| Loan Agreement [Member]
Debt Instrument, Face Amount	$ 7.50	$ 7.50

XML 27 R16.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies (Details Textual)		1 Months Ended			3 Months Ended		6 Months Ended
	Apr. 28, 2017 USD ($) $ / shares shares	Jun. 30, 2018 USD ($) shares	May 31, 2017 USD ($) shares	Apr. 30, 2017 USD ($) shares	Jun. 30, 2018 USD ($) shares	Jun. 30, 2017 USD ($) shares	Jun. 30, 2018 USD ($) shares	Jun. 30, 2017 USD ($) shares	Jan. 01, 2018 USD ($)	Dec. 31, 2017 USD ($)
Cash, Uninsured Amount \| $		$ 5,400,000			$ 5,400,000		$ 5,400,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount \| shares							4,571,912	2,255,381
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants \| shares						413,701
Share-based Compensation, Total \| $							$ 753,000	$ 159,000
Class of Warrant or Right, Outstanding \| shares		2,045,248			2,045,248	2,011,528	2,045,248	2,011,528
Stock Issued During Period, Shares, Issued for Services \| shares					0	14,493	24,000	28,985
Proceeds from Issuance of Common Stock \| $								$ 16,458,000
Gain (Loss) on Conversion of Debt \| $						$ (430,000)		(1,356,000)
Gain (Loss) on Issuance of Common Stock \| $						(145,000)		(145,000)
Income Tax Expense (Benefit), Total \| $						1,000	0	2,000
Fair Value Adjustment of Warrants \| $					19,000	$ (6,950,000)	29,000	(1,769,000)
Retained Earnings (Accumulated Deficit), Ending Balance \| $		$ (299,865,000)			(299,865,000)		(299,865,000)		$ (291,447,000)	$ (293,324,000)
Contract with Customer, Liability, Current \| $		$ 3,416,000			$ 3,416,000		$ 3,416,000		1,037,000	$ 2,914,000
Accounting Standards Update 2014-09 [Member]
Retained Earnings (Accumulated Deficit), Ending Balance \| $									1,877,000
Contract with Customer, Liability, Current \| $									$ (1,877,000)
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio				6
Chairman and Chief Executive Officer [Member]
Deferred Salary Settled by Shares \| $				$ 1,100,000
Common Stock Issued for Settlement of Deferred Salary Balance \| shares				233,734
Gain (Loss) on Issuance of Common Stock \| $				$ (83,807)
Several Investors, Including Acuitas and Shamus [Member] \| Convertible Debentures [Member]
Debt Conversion, Converted Instrument, Shares Issued \| shares				2,982,994
Gain (Loss) on Conversion of Debt \| $								$ (1,400,000)
Public Offering [Member] \| Joseph Gunnar & Co., LLC [Member]
Stock Issued During Period, Shares, New Issues \| shares	3,125,000
Shares Issued, Price Per Share \| $ / shares	$ 4.80
Shares Issued, Price Per Share, Net \| $ / shares	$ 4.464
Proceeds from Issuance of Common Stock \| $	$ 15,000,000
Over-Allotment Option [Member] \| Joseph Gunnar & Co., LLC [Member]
Stock Issued During Period, Shares, New Issues \| shares			303,750
Proceeds from Issuance of Common Stock \| $			$ 1,500,000
Additional Shares Available for Purchase \| shares	468,750
Warrants Related to Investor Relations Services [Member]
Class of Warrant or Right, Issued During Period \| shares					0	90,000	24,000	90,000
Warrants Issued in Connection with A/R Facility [Member]
Class of Warrant or Right, Issued During Period \| shares		9,720
Warrants Not Subject to Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares		11,049			11,049		11,049
Minimum [Member] \| Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life							2 years
Minimum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life							5 years
Maximum [Member] \| Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life							7 years
Maximum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life							7 years
The 2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized \| shares		2,333,334			2,333,334		2,333,334
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period							10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance \| shares		2,526,664			2,526,664		2,526,664
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares \| shares							368,609
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant \| shares		50,523			50,523		50,523
Share-based Compensation, Total \| $					$ 425,000	$ 32,000	$ 753,000	$ 159,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross \| shares					642,307	0	642,307	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total \| $		$ 6,700,000			$ 6,700,000		$ 6,700,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition							3 years 182 days
The 2017 Stock Incentive Plan [Member] \| Nonemployees [Member]
Share-based Compensation, Total \| $					$ 0	$ 0	$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross \| shares					0	0	0	0
The 2017 Stock Incentive Plan [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							3 years
The 2017 Stock Incentive Plan [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							5 years
The 2010 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized \| shares		243,853			243,853		243,853
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Number of Major Customers					2		5
Concentration Risk, Percentage					36.00%		93.00%
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member] \| Customer One [Member]
Concentration Risk, Percentage					19.00%		26.00%
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member] \| Customer Two [Member]
Concentration Risk, Percentage					17.00%		25.00%
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member] \| Customer Three [Member]
Concentration Risk, Percentage							16.00%
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member] \| Customer Four [Member]
Concentration Risk, Percentage							15.00%
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member] \| Customer Five [Member]
Concentration Risk, Percentage							11.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Number of Major Customers							3
Concentration Risk, Percentage							71.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer One [Member]
Concentration Risk, Percentage							42.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer Two [Member]
Concentration Risk, Percentage							17.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer Three [Member]
Concentration Risk, Percentage							12.00%

XML 28 R17.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues	$ 3,273	$ 1,665	$ 5,184	$ 3,487
Revenues, percentage	100.00%		100.00%
Commercial [Member]
Revenues	$ 2,145		$ 3,245
Revenues, percentage	66.00%		63.00%
Government Contract [Member]
Revenues	$ 1,128		$ 1,939
Revenues, percentage	34.00%		37.00%

XML 29 R18.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Calculation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Net loss	$ (4,200)	$ 13,925	$ (8,418)	$ (7,843)
Basic weighted number of shares outstanding (in shares)	15,913,000	13,885,000	15,906,000	11,578,000
Shares issuable for stock options and warrants (in shares)		413,701
Shares used in calculation - diluted (in shares)	15,913,000	14,299,000	15,906,000	11,578,000
Basic net income (loss) from operations per share: (in dollars per share)	$ (0.26)	$ 1	$ (0.53)	$ (0.68)
Diluted net income (loss) from operations per share: (in dollars per share)	$ (0.26)	$ 0.97	$ (0.53)	$ (0.68)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Employee and Director Stock Option Activity (Details) - Employees and Directors [Member]	6 Months Ended
	Jun. 30, 2018 $ / shares shares
Balance, shares (in shares) \| shares	1,885,383
Balance, weighted average exercise price (in dollars per share) \| $ / shares	$ 11.46
Granted, shares (in shares) \| shares	642,307
Granted, weighted average exercise price (in dollars per share) \| $ / shares	$ 7.50
Cancelled, shares (in shares) \| shares	(1,026)
Cancelled, weighted average exercise price (in dollars per share) \| $ / shares	$ 546.19
Balance, shares (in shares) \| shares	2,526,664
Balance, weighted average exercise price (in dollars per share) \| $ / shares	$ 10.24

XML 31 R20.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Total assets	$ 71
Warrant liabilities	59	$ 30
Total liabilities	59
Certificates of Deposit [Member]
Certificates of deposit	71
Fair Value, Inputs, Level 1 [Member]
Total assets	71
Warrant liabilities
Total liabilities
Fair Value, Inputs, Level 1 [Member] \| Certificates of Deposit [Member]
Certificates of deposit	71
Fair Value, Inputs, Level 2 [Member]
Total assets
Warrant liabilities
Total liabilities
Fair Value, Inputs, Level 2 [Member] \| Certificates of Deposit [Member]
Certificates of deposit
Fair Value, Inputs, Level 3 [Member]
Total assets
Warrant liabilities	59
Total liabilities	59
Fair Value, Inputs, Level 3 [Member] \| Certificates of Deposit [Member]
Certificates of deposit

XML 32 R21.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - Warrants [Member] - Fair Value, Inputs, Level 3 [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)
Balance	$ 30
Issuance (exercise) of warrants, net
Change in fair value	29
Balance	$ 59

XML 33 R22.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Summary of Amounts and Classification of Assets and Liabilities of the VIE in Our Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Cash and cash equivalents	$ 5,603	$ 4,779	$ 9,222	$ 851
Accounts payable	1,215	980
Total liabilities	12,525	$ 5,706
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member] \| TIH [Member]
Cash and cash equivalents	96
Accounts payable	7
Accrued liabilities	50
Total liabilities	$ 57

XML 34 R23.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details)	Jun. 30, 2018 yr
Measurement Input, Price Volatility [Member]
Warrant liability assumptions	102.9
Measurement Input, Risk Free Interest Rate [Member]
Warrant liability assumptions	2.52
Measurement Input, Expected Term [Member]
Warrant liability assumptions	1.79
Measurement Input, Expected Dividend Rate [Member]
Warrant liability assumptions	0

XML 35 R24.htm IDEA: XBRL DOCUMENT

Note 3 - ASC 606 - Adoption of ASC 606 (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jan. 01, 2018	Dec. 31, 2017
Deferred revenue	$ (3,416)		$ (3,416)		$ (1,037)	$ (2,914)
Accumulated deficit	(299,865)		(299,865)		(291,447)	$ (293,324)
Healthcare services revenues	3,273	$ 1,665	5,184	$ 3,487
Net loss	(4,200)	$ 13,925	(8,418)	$ (7,843)
Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Healthcare services revenues	1,734		2,886
Net loss	(5,739)		(10,716)
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Healthcare services revenues	1,539		2,298
Net loss	$ 1,539		$ 2,298
Accounting Standards Update 2014-09 [Member]
Deferred revenue					1,877
Accumulated deficit					$ 1,877

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 36 R25.htm IDEA: XBRL DOCUMENT

Note 4 - Long-term Debt (Details Textual) - USD ($)	1 Months Ended	3 Months Ended	6 Months Ended
Note 4 - Long-term Debt (Details Textual) - USD ($)	Jun. 30, 2018	Jun. 30, 2018	Jun. 30, 2018	Dec. 31, 2017
Debt Instrument, Unamortized Discount, Total	$ 434,000	$ 434,000	$ 434,000	$ 0
Heritage Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	9,720	9,720	9,720
Corporate Finance [Member] \| A/R Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,500,000	$ 2,500,000	$ 2,500,000
Line of Credit Facility, Percentage of Accounts Receivable as Borrowings	85.00%	85.00%	85.00%
Line of Credit Facility, Commitment Fee Percentage			1.00%
Debt Instrument, Term			2 years
Debt Issuance Costs, Gross	$ 248,000	$ 248,000	$ 248,000
Amortization of Debt Issuance Costs		6,000	$ 6,000
Prime Rate [Member] \| Corporate Finance [Member] \| A/R Facility [Member]
Debt Instrument, Basis Spread on Variable Rate			3.00%
Loan Agreement [Member]
Debt Instrument, Face Amount	5	5	$ 5
Debt Instrument, Face Amount of Potential Additional Loan	2.50	$ 2.50	2.50
Debt Instrument, Billings Threshold for Additional Loan	$ 5,000,000		5,000,000
Debt Instrument, Billings Threshold for Extension			$ 20,000,000
Debt Instrument, Interest Rate, Stated Percentage	8.75%	8.75%	8.75%
Debt Instrument, Quarterly Revenue Based Payments, Percentage of Consolidated Revenue Payments when EBITDA is Negative			0.20%
Debt Instrument, Quarterly Revenue Based Payments, Percentage of Consolidated Revenue Payments when EBITDA is Positive			0.40%
Debt Instrument, Final Payment, Percent of Each Loan Tranche			6.00%
Debt Instrument, Prepayment Penalty Fee, During Interest-only Payment Period, Percent			3.00%
Debt Instrument, Prepayment Penalty Fee, After Interest-only Payment Period, Percent			2.00%
Interest Expense, Debt, Total		$ 23,000	$ 23,000
Debt Instrument, Interest Rate, Additional Default Amount	5.00%	5.00%	5.00%
Debt Instrument, Late Payment Fee, Percent	6.00%	6.00%	6.00%
Debt Instrument, Fee Amount	$ 75,000	$ 75,000	$ 75,000
Debt Instrument, Unamortized Discount, Total	438,000	438,000	438,000
Amortization of Debt Discount (Premium)		4,000	4,000
Loan Agreement [Member] \| Maximum [Member]
Debt Instrument, Face Amount	$ 7.50	$ 7.50	$ 7.50
Loan Agreement [Member] \| Minimum [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate, Threshold Percent			2.00%

XML 37 R26.htm IDEA: XBRL DOCUMENT

Note 5 - Subsequent Events (Details Textual)	Aug. 13, 2018 shares
The 2017 Stock Incentive Plan [Member] \| Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	1,400,000

EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end